Skip to main content
Frontiers in Chemistry logoLink to Frontiers in Chemistry
. 2023 May 10;11:1158198. doi: 10.3389/fchem.2023.1158198

Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases

Priya Chaudhary 1, Pracheta Janmeda 1,*, Anca Oana Docea 2, Balakyz Yeskaliyeva 3,*, Ahmad Faizal Abdull Razis 4,5,*, Babagana Modu 5,6, Daniela Calina 7,*, Javad Sharifi-Rad 8,*
PMCID: PMC10206224  PMID: 37234200

Abstract

Introduction: Free radicals are reactive oxygen species that constantly circulate through the body and occur as a side effect of many reactions that take place in the human body. Under normal conditions, they are removed from the body by antioxidant processes. If these natural mechanisms are disrupted, radicals accumulate in excess and contribute to the development of many diseases.

Methodology: Relevant recent information on oxidative stress, free radicals, reactive oxidative species, and natural and synthetic antioxidants was collected by researching electronic databases such as PubMed / Medline, Web of Science, and Science Direct.

Results: According to the analysed studies, this comprehensive review provided a recent update on oxidative stress, free radicals and antioxidants and their impact on the pathophysiology of human diseases.

Discussion: To counteract the condition of oxidative stress, synthetic antioxidants must be provided from external sources to supplement the antioxidant defense mechanism internally. Because of their therapeutic potential and natural origin, medicinal plants have been reported as the main source of natural antioxidants phytocompounds. Some non-enzymatic phytocompounds such as flavonoids, polyphenols, and glutathione, along with some vitamins have been reported to possess strong antioxidant activities in vivo and in vitro studies. Thus, the present review describes, in brief, the overview of oxidative stress-directed cellular damage and the unction of dietary antioxidants in the management of different diseases. The therapeutic limitations in correlating the antioxidant activity of foods to human health were also discussed.

Keywords: free radicals, oxidative stress, pathophysiology, chronic diseases, phytochemicals, antioxidants

1 Introduction

Human beings have always involved themselves in various activities to ensure their wellbeing and survival. In doing so, the human body has directed the release of different free radicals or reactive substances which are either inhaled or consumed (Engwa, 2018). The reactive nitrogen and oxygen species (RNS/ROS) play a twofold role as both toxic and beneficial compounds to the organism’s system. At lower concentrations, they have beneficial effects and indulged in different physiological processes such as redox regulation, mitogenic responses, cellular signaling pathways, and an immune function while at a higher level, these reactive species generate nitrosative and oxidative stress (Phaniendra et al., 2015). To reduce or prevent free radical-directed oxidative damage, the human body has developed an antioxidant defence mechanism that involves free radical scavenging, metal chelating, and enzymatic activities to neutralize the reactive species just after they have formed. In addition, the consumption of dietary antioxidants can maintain an adequate level of antioxidants in the organism’s body (Lobo et al., 2010). The level of reactive species in the cellular system may be reduced by antioxidants either by restricting the expression or activities of free radical-producing enzymes such as xanthine oxidase (XO) and NAD(P)H oxidase, or by enhancing the expression and activities of antioxidant enzymes such as glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD) (Aziz et al., 2019). The growing interest in antioxidants among the public, health professionals, and food scientists is due to their protective function in food items against oxidative deterioration and the organism body against oxidative stress-directed abnormal processes. These potent natural antioxidants are in huge demand for pharmaceuticals/nutraceuticals and as food preservatives. Effective search for new sources of naturally occurring antioxidants and formulation of new antioxidant compounds need reliable methods for evaluation of the antioxidant activity. Many biological models, food models, and chemical assays have been developed that can measure the reducing power, radical scavenging activity and other related attributes along with overall oxidation inhibition in the more complex biological system and food items. These processes vary in terms of ease of operation, result expression, oxidation initiator, substrate type, and antioxidant mechanism. Selection of a specific or combination of the method is required for the proper assessment of antioxidant potential as a health-enhancing agent or as a food preservative (Shahidi and Zhong, 2015; Chaudhary and Janmeda, 2022a). Thus, the current review updates the current information about free radicals, their origin, types, and antioxidants with their mode of action against reactive species. This paper is found to be very helpful for scientists and researchers who are working on the investigation of the molecular and chemical mechanism of antioxidants. It also benefits the physician who is interested in antioxidant therapy for the cure of diseases.

2 Methodology

Relevant recent information on oxidative stress, free radicals, reactive oxidative species, and natural and synthetic antioxidants was collected by researching electronic databases such as PubMed/Medline, Web of Science, and Science Direct using the following MeSH terms: “Antioxidants/analysis”, “Antioxidants/metabolism”, “Antioxidants/therapeutic use”, “Diet”, “Food Analysis, Forecasting, Free Radicals/adverse effects”, “Free Radicals/antagonists and inhibitors”, “Free Radicals/metabolism”, “Humans”, “Lipid Peroxidation/physiology”, “Reactive Oxygen Species/adverse effects”, “Reactive Oxygen Species/metabolism”, “Reactive Oxygen Species/therapeutic use”, “Antioxidants/metabolism Free Radicals/adverse effects”, “free Radicals/metabolism”, “Humans Oxidative Stress Oxygen/metabolism”. The taxonomy of the plants mentioned in this review was verified using “The PlantList”.

3 Reactive oxygen species (ROS): From physiology to pathology

Free radicals are molecular species that exist independently and contain an unpaired form of an electron in their atomic orbital. These radicals are highly unstable and reactive. They either donate or accept an electron, therefore acting as oxidants and reductants (Lobo et al., 2010). The generation of highly reactive ROS is an important feature of the normal cellular system such as fertilization, ovulation, arachidonic acid metabolism, phagocytosis, and mitochondrial respiratory chain. Their generation gets multiplies many folds during pathological complications. During the recovery phases, the release of oxygen-free radicals has been observed from many pathological stimuli and reached cerebral tissue (Snezhkina et al., 2020). Reactive species include nitric oxide (•NO), alkoxy (-OR), peroxyl (ROO·), hydroxyl (·OH), hydrogen peroxide (H2O2), and superoxide (O2 .-), respectively. Majorly the superoxide radicals are generated from microsomal and mitochondrial electron transport chains. Except for cytochrome oxidase which retains the reduced form of oxygen intermediates to their active site, all the other elements of the mitochondrial respiratory chain transfer the electrons directly to oxygen and do not retain any reduced intermediate of oxygen at their active site to protect the cell against oxidative damages. On the internal membrane of mitochondria, the superoxide anions may be produced by the auto-oxidation of semiquinones. A major part of mitochondrial-generated superoxide anions is dismutation to H2O2. The alkoxyl and hydroxyl free radicals are reactive and rapidly target the major macromolecules in cells (Strzelak et al., 2018). Free radicals produced by ROS direct undesirable changes and result from lipid peroxidation, DNA fragmentation, cell death, DNA damage, protein modification, and membrane damage. This oxidative stress is not only involved in the toxicity of xenobiotics but also in the pathophysiology of various ailments like ischaemia reperfusion injury, vascular endothelium, deep injuries, organ dysfunction, shock, inflammation, sepsis, diabetic retinopathy, cancer, cognitive dysfunction, cataract, and heart disease. Alterations in the concentration of iron have been observed in amyotrophic lateral sclerosis, spastic paraplegia, and multiple sclerosis which strengthens the knowledge that the accumulation of iron is a secondary factor that is related to neurodegenerative diseases. It can also be associated with gliosis in the affected area or alter the integrity of the blood-brain barrier resulting in inflammatory events and altered tissue vascularization (Stephenson et al., 2014).

3.1 Roles of ROS and NO in the pathophysiology of human diseases

3.1.1 Oxidative stress, ROS, inflammatory markers and different types of cancer: Connecting the dots

3.1.1.1 Role in carcinogenesis

The mechanism of carcinogenesis is divided into different stages: progression, promotion, and initiation. In the initiation stage, an endogenous or exogenous carcinogen induces certain changes in the DNA of a cell. This causes an abnormal change that can be inheritable and confers that the cell has the capacity for neoplastic growth (Klaunig and Kamendulis, 2004). This is reported after the metabolic activation of a procarcinogen, which includes oxidative metabolism directed by phase I enzyme to produce reactive oxygen species and electrophiles. The potency of carcinogens is determined by the ability to induce heritable alterations in the specific gene or by the stability of adducts formed with DNA (Klaunig and Kamendulis, 2004). DNA damage is the main cause of several diseases like cancer. The main focus has been given to the consequences and extent of Dfocusations in response to oxygen radicals and other associated reactive species. ROS damaged the cellular DNA which is determined to be a main carcinogenic factor This mis-repaired DNA can result in mutations. These mutations carried out the conversion of a proto-oncogene into a carcinogenic oncogene, which is responsible for different types of cancer (Marnett, 2000). The main damage is the generation of hydroxylated bases of DNA, which is regarded as a crucial event in the process of chemical carcinogenesis (Marnett, 2000). RNS/ROS can cause damage to nucleic acid. The mitochondrial DNA is more prone to get attached by ROS as compared to the nuclear DNA because it is present close to the site of ROS generation. Hydroxyl radicals directly target the different components of DNA such as deoxyribose sugar backbone, pyrimidine and purine bases, and result from single and double-stranded breaks in the DNA (Nita and Grzybowski, 2016). The purine targeted by hydroxyl radical generates various purine adducts like 2,6-diamino-4-hydroxy-5-formamidopyrimidine, 8-hydroxy deoxy adenosine, and 8-hydroxydeoxy guanosine. The pyrimidine adducts formed by the attack of hydroxy radical include hydantoin, 5-hydroxy deoxycytidine, 5-hydroxydeoxy uridine, uracil glycol, and thymine glycol, respectively. On another side, the RNS, mainly the peroxynitrite (ONOO) interact with guanine to generate oxidative and nitrative DNA damage such as 8-oxodeoxyguanosine and 8-nitroguanine, respectively (Phaniendra et al., 2015).

3.1.1.2 Chronic inflammation, cancer and ROS

The main component in the relationship between chronic inflammation and cancer is ROS as shown in Figure 1. It can target the level, presence, and type of modulating factors related to inflammation such as growth factors, chemokines, inflammatory cytokines, p53, peroxisome proliferated-activated receptor gamma (PPAR-γ), NF-kB, hypoxia-inducible factor (HIF-1α), ß-catenin/Wnt (wingless related integration site), and activator protein 1 (AP-1) (Reuter et al., 2010; Kashyap et al., 2019). There is typical crosstalk between cancer progression, ROS accumulation, and chronic inflammation Under tumor microenvironment, inflammatory cells direct a massive generation of ROS by the activation of oxidant-generating enzymes such as upregulation of lipoxygenase (LOX), myeloperoxidase (MPO), cyclooxygenase 2 (COX2), xanthine oxidase (XO), NADPH oxidase, and inducible nitric oxide synthase (iNOS) to disrupt the physical, chemical, and biological factors. Excessive ROS accumulation causes oxidative damage to mitochondria, lipids, proteins, RNA, and DNA (Reuter et al., 2010; Kashyap et al., 2019).

FIGURE 1.

FIGURE 1

Illustrative scheme regarding the correlation between chronic inflammation and cancer mechanisms. Abbreviations and symbols: ↑increase, ↓decrease, ROS (reactive oxidative species), NO (nitric oxide), NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells).

3.1.1.3 Cancer metastasis and ROS

Excessive level of ROS leads to metastasis via the stimulation of mitogen-activated protein kinase (MAPK), and phosphoinositide-3-kinase regulatory subunit/AKT serine/threonine kinases/mechanistic target of rapamycin kinase (PI2K/Akt/mTOR) signaling pathways that directs the activation of downstream metalloproteinase 9 (MMP9), metalloproteinase 2 (MMP2), SNAIL enzymes which initiate epithelial-mesenchymal transition (EMT) to metastasis (Deepika et al., 2013). The ROS results in genetic instability due to mutation load and DNA damage. Exposure to ROS can also bring modulation the expression of different transcription factors such as nuclear factor kappa B (NF-kB), and activator protein 1 (AP-1), involved in cancer stem cell maintenance, metastasis, and proliferation. It is determined that ROS are implicated in different cancer-associated processes such as angiogenesis, inflammation, metastasis, and apoptosis (Kashyap et al., 2019).

3.1.1.4 Pro-angiogenic role of ROS

Activation of angiogenesis through ROS via vascular endothelial growth factor (VEGF) independent and VEGF dependent pathways are shown in Figure 2. The VEGF-dependent pathway raises the expression of vascular endothelial growth factor (VEGF) via MAPK (Mitogen-activated protein kinases), and the phosphoinositide-3-kinase regulatory subunit/AKT serine/threonine kinases/mechanistic target of rapamycin kinase (PI3K/Akt/mTOR), PTEN (phosphatase and tensin homolog) signaling pathway via p70S6K1 (ribosomal protein S6 kinase B1) and HIF-1α (Hypoxia-inducible factor1-alpha), that releases different growth factors, cytokines, and undergo the upregulation of MMPs which leads to angiogenesis. Whereas the VEGF-independent pathway results in angiogenesis via oxidative ligands of lipids which activate NF-kB via Toll-like receptor (TLR) (Deepika et al., 2013).

FIGURE 2.

FIGURE 2

Angiogenesis through the activation of reactive oxygen species. Abbreviations and symbols: ↑ increased, ↓ decreased, ROS reactive oxygen species, TLR Toll-like receptors, VEGFR Vascular endothelial growth factors, NF-kβ nuclear factor kappa B, MAPK mitogen-activated protein kinase, HIF-1α (Hypoxia-inducible factor 1-alpha).

3.1.1.5 Lung cancer

The lung is the only organ that is under more exposure to ambient air than the skin. It is therefore easily affected by oxidants, pathogens, pollutants, gases, and inhaled toxins. In addition, endogenous oxidants produced by different pathophysiological processes in the lung and anywhere in the body also increased the oxidative burden. To control these effects, the epithelium of the lung is protected by a lining of fluid containing an armamentarium of antioxidants. When the equilibrium between the antioxidants and oxidants is compromised then it leads to oxidative stress. In response to this stress, an inflammatory response is directed which results in the release of different cytokines and pro-inflammatory chemokines. This leads to the invasion of leukocytes and monocytes into the inflammatory environment. Continuous inhalation of injurious agents directs the initiation of prolonged oxidative stress in the lungs, which results in chronic inflammation characterized by a pronounced release of reactive nitrogen and oxygen species. This condition is related to significant DNA damage and genomic instability, leading to neoplastic progression and initiation (Valavanidis et al., 2013).

3.1.1.6 Liver cancer

Different evidence has shown that oxidative stress plays a potent role in the development of hepatic carcinogenesis by disrupting genetic material, the normal functioning of the cell, and by interfering with various pathways of cell signaling (Jain et al., 2020). The application of antioxidant agents can limit oxidative stress-directed damages in vitro. But no drug is found to be effective under in vivo conditions with a smaller number of side effects. To find a more effective method for the cure and treatment of HCC, research for a better understanding of the mechanism involved in the development of cancer, OS-induced damage, and the effects of antioxidants is urgently required (Wang et al., 2016).

The liver is the main organ that is targeted by reactive species. Primary cells, i.e., parenchymal cells subjected to oxidative stress-directed damage in the liver (Jain et al., 2020). The peroxisomes, microsomes, and mitochondria in parenchymal cells lead the production of ROS by regulating the PPARα, which is involved in the expression of genes related to fatty acid oxidation. Moreover, endothelial cells, hepatic stellate cells, and kupffer cells are more sensitive towards oxidative stress-associated molecules. Different types of cytokines such as TNF-α can be released in Kupffer cells in response to oxidative stress, which might trigger the process of apoptosis and inflammation (Li S et al., 2015).

3.1.1.7 Colorectal cancer

Colorectal cancer is the most common cancer globally, with the greatest incidence in Western nations. This cancer arises from the epithelial cells that line the bowel. The epithelial cells reported to have a great metabolic rate and divide rapidly which has been considered to be a potent factor responsible for the oxidation of DNA. Studies on rat colonocytes reported that the lower crypt cells are very much more sensitive towards hydrogen peroxide-induced damage than the differentiated cells located at the crypt surface (Perše, 2013). Since proliferating cells in the colon are present in the lower part of the crypt, this may determine that these cells are supposed to be the main targeted cells in case of colon carcinogenesis Progenitors or stem cells are very sensitive towards the redox environment. The differentiation and self-renewal of these cells are based majorly on the redox environment of the gut mucosa. Proliferating cells are also found to be sensitive to DNA damage as DNA is available in the form of a sgle strands in the S-phase of the cell cycle and further serves as a template in daughter cells. The damage of DNA in a single strand can lead to multiple mutations in the DNA of daughter cells, which could not get repaired (Oberreuther-Moschner et al., 2005). DNA damage causes genomic instability, replication error, induction of signal transduction pathways, induction of transcription and cell cycle arrest, all of which are related to colon carcinoma. However, the latest investigation has reported that the production of ROS may play a vital role in all the phases of carcinogenesis, i.e., progression, promotion, and initiation (Valko et al., 2007).

3.1.1.8 Breast cancer

Breast tumor with increased proliferative capacity produces a great level of ROS during the chronic cycles of angiogenesis, reperfusion, and ischemia. Tumor cells can direct oxidative damage in surrounding healthy tissues. Enhanced levels of circulating malondialdehyde has been observed in the advanced stages of breast cancer as compared to early stages, which shows differences in the stage of oxidative stress. Patients with breast cancer have been reported to have a greater level of malondialdehyde, a marker of oxidative stress and peroxidation product, than the control patients (Coughlin, 2018). A breast tumor is a highly complex structure composed of old stromal and neoplastic cells. Carcinoma-associated fibroblasts (CAFs) has been usually reported in the cancer stroma, where they enhance vascularity and tumor growth. Under the influence of oxidative stress, fibroblast gets activated to become myofibroblast. These cells are greatly contractile and mobile and more often express mesenchymal markers. The activation of CAF is irreversible, which makes it difficult to be removed by nemesis. In cases of breast tumor, around 80% of stromal fibroblast needs an activated phenotype that manifests by the release of an enhanced level of metalloproteinase, cytokines, and growth factors. They also generate hydrogen peroxide, which directs the production of different sets of tumorigenic alterations and activated fibroblasts in the case of epithelial cells. Under oxidative stress, the tumor stroma produces a wide range of nutrients that support cancer cell survival and growth (Jezierska-Drutel et al., 2013).

3.1.1.9 Prostate cancer

Prostate cancer is very common among males in Western nations. This chronic disease is very difficult to diagnose and has very limited treatment options. In vivo and in vitro studies determine oxidative stress as the main factor responsible for the occurrence of chronic prostatitis, prostatic cancer, and benign prostatic hyperplasia. Thus, the cascade of oxidative stress is the potential target for the cure of prostate-related disorders (Roumeguére et al., 2017).

3.1.2 Roles of ROS in the pathophysiology of other diseases

3.1.2.1 Liver diseases

The liver is the second largest organ in the organism’s body. It includes a broad range of vital functions such as storage of material absorbed from the digestive tract, hormone catabolism, synthesis of different compounds like clotting factors, globulin, and albumin and detoxification reactions. In alcoholic individuals, the main organ responsible for the removal of excessive alcohol is the liver and hence alcoholics are more prone to liver damage. Alcohol gets metabolized in the liver and during its metabolism, it generates free radicals. Metabolism of ethanol results in oxidative stress in hepatocytes through the generation of ROS. During metabolism, the molecules of alcohol break down into smaller molecules, which after further reactions leads to the production of ROS in the liver organ (Ceni et al., 2014), Figure 3. Alcohol promotes the production of ROS in various ways: 1) stimulating cytochrome P450s activity, 2) altering certain metal concentrations, 3) decreasing the antioxidants level, 4) directing the conversion of xanthine dehydrogenase (XDO) into xanthine oxidase (XO). These radicals raise peroxidation of lipids which leads to liver disorders such us: 1) Ischemic reperfusion injury (IRI): ROS generated by activated liver cells act as a vital mediator in liver ischemic-reperfusion injury (Zhang W et al., 2007) 2) Alcohol-induced oxidative stress: In ethanol-associated liver disorders, ROS plays an important role (Tan et al., 2020).

FIGURE 3.

FIGURE 3

Highlights the impact of ROS in chronic diseases: liver, renal and kidney. Abbreviations and symbols: ↑ (increased), ↓ (decreased), ROS (reactive oxidative species), XDO (xanthine dehydrogenase), XO (xanthine oxidase), DNA (Deoxyribonucleic Acid).

3.1.2.2 Renal diseases

The kidney is greatly vulnerable to alterations induced by ROS because of polyunsaturated fatty acids in the lipids of the kidney (Ander et al., 2003). The renal sources of ROS are leucocytes, fibroblasts, glomerular cells, interstitial cells, vascular cells, and activated macrophages. Oxidative stress played a potent role in various renal diseases such as tubule-interstitial fibrosis, ischemia-reperfusion injury, progressive and acute renal failure, and glomerulosclerosis (Ratliff et al., 2016; Duni et al., 2019), (Figure 3). Oxygen radical results in the following changes: 1) These free radicals result in hypertrophy of tubular cells, 2) Oxygen radical reacts with nitric oxide which is an endothelial vasodilator and inhibits its function. The products generated in this reaction are peroxynitrite (ONOO) which results from the formation of hydroxyl radical (·OH), which is greatly reactive and results in the alteration of cellular functioning and cause dysfunction of endothelial cells, and 3) Massive generation of O2 may result in proliferation and apoptotic death of epithelial cells (Pacher et al., 2007; Ratliff et al., 2016). Generally, renal patients required regular dialysis and this process undergoes the removal of small antioxidant molecules from the blood. This decreases the protection against reactive species and causes peroxidation of several biomolecules such as lipids. This raised the level of oxidative stress that can further lead to renal complications (Liakopoulos et al., 2017).

3.1.2.3 Lung diseases

The lung organ exists in an oxygen-rich environment. Their large blood supply and greater surface area make this organ more susceptible to damage caused by oxidative stress. Exposure to exogenous ROS such as cigarette smoke, airborne particulate matter, and carbonyls/aldehydes, can result in oxidative stress and triggers the inflammation response in the lungs. On another side, an insufficient antioxidant defence mechanism in inflammatory cells, macrophages and lung epithelial cells can also result in high-level production of endogenous ROS in the lung tissues (Park et al., 2009; Pereira and Martel, 2014; Maynard, 2015; Bhatia, 2017). Mitochondria are majorly included in ROS-dependent pathways. Mitochondrial dysfunction also plays an important role in non-energetics pathogenesis and bioenergetics metabolism in different cases of lung disease. The genome of mitochondria acts as a guard to govern the cytotoxic response of pulmonary cells to oxidant stress (Schumacker et al., 2014; Kim et al., 2015). Mitochondria are included in ROS-initiated lung diseases such as lung cancer, chronic airway disease, asbestos, and lung fibrosis. The mitochondrial genome is more sensitive than the nuclear genome. Damage to mitochondrial DNA results in loss of mitochondrial membrane potential, impairment in the electron transport chain, and drives the immune and inflammatory responses (Liu and Chen, 2017), (Figure 3).

3.1.2.4 Neurological disease

Neurodegenerative diseases are a heterogenous group of disorders that are characterized by the extensive loss of neurons. In the case of cerebral ischemia (CI), oxidative stress takes part in neuroinflammatory reactions. In postischemia brains, oxidative stress directs the activation of astrocytes and microglia which brings striking elevation in the inflammatory mediators such as matrix metalloproteases, chemokines, and cytokines and results in the loss of endothelial cell integrity in the brain by upregulating the neutrophil infiltration and cell adhesion molecules. M any studies reported that both nondopaminergic and dopaminergic cells undergo degeneration in the case of Parkinson’s disease. (Kim et al., 2015).

The innate mechanism of PD involves inflammatory responses and a spectrum of oxidative stress that results in neurodegeneration. Loss of dopaminergic neurons involves neuroinflammatory mechanism and oxidative stress through the elevated level of inducible nitric oxide synthase (iNOS) followed by activated astrogliosis, T-cell infiltration, and microglia that leads to the accumulation of NO and O2 free radicals. Overexpression of cyclooxygenase-2 (COX2) is also responsible for dopaminergic neuronal loss via oxidative stress-mediated inflammation. In addition, the increasing level of myeloperoxidase by reactive astrocytes could also raise the level of reactive NO2 and ∙OH radicals that could result in neuronal loss in Parkinson’s disease. Enhanced OS may direct mitochondrial dysfunction, impairment in the DNA repair system, and cellular damage, all of these processes have been regarded as the key factor responsible in the acceleration of the aging process and the initiation of other neurological diseases (Kim et al., 2015).

3.1.2.5 Cardiovascular disease

ROS work as a secondary messenger within the heart as they are indulged in various physiological processes including contraction-excitation, proliferation, and differentiation. However, when the generation of ROS exceeds the level of antioxidant molecules in the heart, oxidative stress arises, which results from heart failure, cell death, hypertrophy, ischemia-reperfusion injury, and cardiac dysfunction. Endogenous ROSs in the heart are produced by uncoupled nitric oxide synthase, monoamine oxidases, cytochrome P450, NADPH oxidase, and xanthine oxidoreductase. ROS are also responsible for the initiation of some problems associated with specific clinical settings, comprising POAF, and chemotherapy-directed cardiotoxicity, as well as in the condition of diabetic cardiomyopathy, which determines a type of heart disorder in diabetic patients in the absence of other complications related to diabetes (D’Oria et al., 2020).

3.1.2.6 Rheumatoid arthritis

Rheumatoid arthritis (RA) is a condition which gives rise to oxidative stress. A 5-fold increase in the concentration of mitochondrial ROS in monocyte and whole blood of RA patients is reported as compared with a healthy individual which suggests that OS has a pathogenic effect in RA. (Ponist et al., 2019; Yadav et al., 2023). Free radicals or reactive species are indirectly associated with joint damage, as they play the role of secondary messenger in the immune and inflammatory response in RA. The exposure of T-cells to raised OS become refractory to different stimuli including those for death and growth and may preserve the abnormal immune response. On the other hand, free radicals directly degrade the joint cartilage by targeting its proteoglycan and restricting its synthesis. Oxidative products of lipid peroxidation, oxidative damage of hyaluronic acid, and oxidation of low-density carbonyl and lipoproteins increment have been observed in RA patients. Raised levels of synovial fluid and 4-HNE have also been determined in the serum of RA patients (Ponist et al., 2019; Yadav et al., 2023).

3.1.2.7 Cataract

A cataract is a partial or complete opacification on or in the human lens or in the capsule, which degrades vision. It is the main cause of reversible blindness in the globe today. It is determined that oxidation is an initial stage in the sequence of steps that lead to cataracts. Researchers have proposed a variety of factors which are related to the onset of cataractogenesis: enhanced permeability of the lens membrane, a decreased function of chaperone related to alpha crystalline, augmented non-enzymatic glycosylation, enhanced lipid peroxidation, and low capacity of antioxidant defence mechanism. These results have shown that the OS plays a major role in the pathogenesis of cataracts, which can be ameliorated and prevented by antioxidant molecules (Kaur et al., 2012).

4 Antioxidants: A brief synopsis

Mizanur Rahaman et al. (2023) Antioxidants work by preventing or delaying the oxidation of chemicals. The initial study on the antioxidant is majorly focused on their application in preventing unsaturated fats from getting rancid. However, the identification of vitamin E, C, and A in the living organism has led to an understandiof ng the function of antioxidants. They are usually divided into non-enzymatic and enzymatic. Among them, there are different types of compounds with different places amodesode of action and varied final effects (Flieger et al., 2021). They act as metal-chelatisynergists synergist, enzyme inhibitor, singscavengersn scavengedecomposerse decomposerdonorsctron donors, hydrogen donor, and radical scavenger (Sharifi-Rad et al., 2022). Both non-enzymatic and enzymatic antioxidants exist in extracellular and intracellular environment to detoxify the ROS. Two main principal mechanisms of action of that described for antioxidants are: The first mechanism is chain breaking in which primary antioxidants donated an electron to the free radicals whereas the second mechanism directs the removal of reactive species initiators (secondary antioxidants) by quenching the catalyst that initiate the chain of reaction. So, antioxidants extra t efonct in biological ssystemswith the help of various mechanisms such as gene expression regulation, co-antioxidants, metal ion chelation, and electron donation (Lobo et al., 2010). Antioxidants are the agent that when available in low concentration in comparison to the oxidizable substrate remarkably reduces or delays the oxidation of the substrate. The organism’s body has developed a different endogenous system to counteract the generation of reactive oxygen intermediates. The endogenous system is further categorized into non-enzymatic and enzymatic groups. The main function of antioxidants is to detoxify the reactive species in the body (Kurutas, 2016). Figure 4 shows the sites of action that are targeted by different antioxidants.

FIGURE 4.

FIGURE 4

Summarized scheme regarding ROS generation at the mitochondrial level.

4.1 Role of endogenous/enzymatic antioxidants

Fortunately, the organism’s body contains a free radical defense mechanism. Every cell releases an antioxidant enzyme which protects the cells during the metabolism of oxygen, and further breaks down the harmful free radicals into balanced molecules like water (Lobo et al., 2010), (Table 2).

TABLE 2.

The role of natural antioxidants in the chemoprevention of cancer.

Dietary agent Chemopreventive effects References
Soy (Flavonoids, Genistein) control cell cycle, ↓topoisomerase IIantioxidant Mehta et al. (2010)
Ursolic acid regulate pro-and anti-apoptotic proteins Iqbal et al. (2018)
↓free radicals, ↑arrest cell cycle, ↑apoptosis
↓angiogenesis, ↓proliferation, ↓metastasis
β-caryophyllene analgesic Fidyt et al. (2016)
β-caryophyllene oxide anticancer properties
Capsaicin ↑autophagy, ↑apoptosis, ↓angiogenesis Zhang J. et al. (2019)
↓proliferation, ↓metastasis
Deoxyelephantopin Isodeoxyelephantopin ↑ apoptosis Mehmood et al. (2017)
Zingerone ↑apoptosis Su et al. (2019)
Isoliquiritigenin ↓angiogenesis Wang et al. (2013)
Indole-3-carbinolGenistein ↑ apoptosis Ushio-Fukai and Nakamura (2008)
Epigallocatechin gallate ↑apoptosis, ↓cell growth, ↓NF-kB Khan et al. (2010)
Sulforaphane ↓histone deacetylase Ho et al. (2009)
Chrysin chemopreventive effect against benzo(a) pyrene-induced lung cancer in swiss albino mice Kasala et al. (2016)
Mangiferin ↓cell-cycle proteins Rajendran et al. (2015)
↓cytokines, ↓inflammatory markers
Piperlongumine ↓NF-kB, ↓ metastasis, ↓cancer cells growth Kumar and Agnihotri (2021)
6-shogaol ↑anticancer effect of irinotecan, oxaliplatin, 5-fluorouracil Woźniak et al. (2020)
↑autophagy, ↑apoptosis on colon cancer cells under hypoxic conditions
Allicin ↓invasion, ↓ proliferation of cells by ↓STAT3 signaling in the case of cholangiocarcinoma Chen et al. (2018)
Baicalein ↓invasion, ↓proliferation of cells, ↓snail-induced epithelial-mesenchymal transition in case of colorectal cancer Zeng et al. (2020)
Gingerol ↑apoptosis, ↑caspases, ↓proliferation of cancer cells Radhakrishnan et al. (2014)
↓ MAPK/AP-1 signaling in case of colon cancer cells
Glycyrrhizic acid ↓proliferation of cells, ↑apoptosis, ↑cell cycle arrest in the case of gastric cancer cells Wang H et al. (2020)
Hispidulin ↑anticancer activity, ↑endoplasmic reticulum stress in the case of non-small cell lung cancer Lv et al. (2020)
Licochalcone A ↓proliferation of cells, ↑ATM-CHEK2, ↑autophagy Shen et al. (2019)
Gallic acid ↓NF-kB Morais et al. (2010)
Curcumin ↓CDK-4 a, ↓Cyclin D1 in the case of breast cancer cells George et al. (2021)
Genistein ↓cancer cell proliferation
↓PTK signaling, ↓protein-tyrosine kinase
Apigenin ↓ HPV-induced prostate cancer
↑apoptosis, alteration of cell cycle
Synthetic agents Chemopreventive effects References
2′,5′-dialkoxylchalcones ↓tubulin polymerization Cheng et al. (2008)
1,4-Phenylenebis (methylene)selenocynate ↓colon tumor incidence Reddy and Lokesh (1992)
butylated hydroxytoluene protective effect against ferric nitrilotriacetate induced oxidative stress and hepatotoxicity Ansar et al. (2013)
Butylated hydroxyanisole ↓ARE-mediated expression of gene Yuan et al. (2006)
↓Nrf2 coupled with JNK
↓ERK signaling pathway in HepG2 cells

Abbreviations and symbols:↑ increase, ↓decrease, NF-kB: Nuclear factor kappa B; STAT3: Signal transducer and activator of transcription 3; MAPK/AP-1: Mitogen-activated protein kinase-Activator protein-1; ATM-CHEK2: Ataxia telangiectasia mutated serine-checkpoint kinase 2; CDK-4: Cyclin-dependent kinase 4; PTK: protein tyrosine kinase; ERK: Extracellular signal-regulated kinase; HepG2: liver cancer cell line.

4.1.1 Superoxide dismutase (SOD)

Living organisms have evolved a system for the scavenging of free radicals and reactive species. Superoxide dismutase carried out the removal of O2 •-.

2O2+2H+SODH2O2+O2

In another step, the hydrogen peroxide generated is eliminated by GPx and catalase system. Various isoenzymes of SOD are indulged in the scavenging activity of free radicals. The first isoenzyme is present in the mitochondria and is Mn2+ dependent whereas another isoenzyme is available in the cytoplasm and is dependent on Cu. Another extracellular Cu-Zn-dependent isoenzyme is also reported. Two different mechanisms have been reported for the SOD action that restricts the transformation 1) It majorly acts at the cell membrane level and eliminate or prevent the generation of radical that can result from the peroxidation of lipid and leads to the chain of extra-nuclear and nuclear events, ultimately cause transformation. This concept explains the model of a membrane that mediates chromosomal aberration, 2) It has been reported that oxygen radicals could be generated in a growth medium and act as a promoter of transformation that will be removed by SOD (Kowald et al., 2006).

4.1.2 Catalase (CAT)

Catalase is present exclusively in peroxisomes. The purified form of catalase contains four subunits of protein, each of which has a heme (Fe III-protoporphyrin) group attached to its active site. Catalase is reported to play a dual role (Nandi et al., 2019).

  • 1. A catalytic role in the decomposition of H2O2

2H2O2Cat2H2O+O2
  • 2. A peroxidic role to oxidize a range of H donors (AH2)

AH2+H2O2PerA+2H2O

DNA cleavage by X-ray and mitomycin C induced malignant transformation which was found to be suppressed by the catalase enzyme. According to some studies, factors such as brain-derived neurotrophic factor (BNDF) and stress are responsible for the antioxidant activity of several endogenous antioxidants (Lobo et al., 2010). The mice with BNDF deficiency under the stress circumstances showed increased activity of catalase enzyme in comparison to the stressed wild type. This indicates that the capacity to scavenge free radicals was reduced and this determines that the normal wild type has better tolerance capability than the BNDF heterogeneous mice (Hacioglu et al., 2016).

4.1.3 Glutathione systems

The system of glutathione includes glutathione-S-transferase, glutathione peroxidase, glutathione reductase, and glutathione. This system is reported in microorganisms, plants and animals. Glutathione peroxidase is an enzyme that contains 4 units of selenium as cofactors which catalyzes the breakdown of organic hydroperoxides and hydrogen peroxides. About four different isoenzymes of glutathione peroxidase are reported in animals. Glutathione peroxidase 1 is the efficient scavenger of hydrogen peroxide while glutathione peroxidase 4 is found to be more effective with lipid hydroperoxides. The glutathione S-transferase shows greater activity with lipid peroxides. These enzymes are present at high concentrations in the liver and also help in the metabolism of detoxification (Lobo et al., 2010).

Glutathione is a non-protein thiol that coordinates the processes of antioxidant defense in the body. Alterations in the status of glutathione have been reported to cause several complications. Administration of thiol compounds such as methionine, cysteine, and glutathione are known to protect against oxidative stress in animals and humans. The reduced form of thiols has been utilized for the recycling of other antioxidants such as vitamin C and vitamin E (Noctor et al., 2011).

4.1.4 Glucose-6-phosphate dehydrogenase

Protection against OS is largely depending upon the reductive power of NADPH, whose level is evaluated with the help of glucose-6-phosphate dehydrogenase (G6PD). Animal cells contain few enzymes that can generate NADPH, and among them, G6PD is the most important one (Peters and Van Noorden, 2009). G6PD catalysis is the rate-limiting step of the pentose phosphate pathway (PPP), which provide nucleotide precursors for DNA replication, as well as reductive power to NADPH for the detoxification of ROS and de novo synthesis of lipid (Stanton, 2012). The relation of PPP and G6PD in the detoxification of ROS is determined by the fact that mice deficient in G6PD have higher levels of oxidative damage in the brain. Animal cells also respond against oxidative stress by enhancing their PPP-directed NADPH production. The overexpression of G6PD in Drosophila melanogaster protects against oxidative stress and can also expand their lifespan (Nóbrega-Pereira et al., 2016).

4.2 Role of exogenous antioxidants

4.2.1 Vitamins and selenium

Exogenous antioxidants like vitamins E, C, and A played a supporting role. They scavenge the free radicals and reactive species by donating an electron and maintaining a chemical balance. These dietary agents get saturated easily, only once as they donate the electron (Table 1).

TABLE 1.

Classification of major antioxidants and their roles.—this Table must totally re-written/updated according to the reviewer 3 comments.

Antioxidant Role References
Enzymatic Superoxide dismutase (SOD) Dismutates O2 •⁻ to O2 with a higher rate of reaction by successive reduction and oxidation of transition metals to H2O2 Buettner (2011)
Catalase Dismutates H2O2 to H2O and oxygen Nandi et al. (2019)
Glutathione peroxidase (GPx) ↓lipid peroxides, ↓H2O2 in the presence of tripeptide glutathione, GPx added two electrons to carried out the reduction of peroxides Lubos et al. (2011)
Non-enzymatic (Vitamins) Alpha-tocopherol major membrane bound antioxidant Traber and Stevens (2011)
↓lipid peroxide scavenge O2 •, •OH radicals
interrupt the chain reaction of free radicals by capturing free radicals
Beta carotene scavenges peroxy, O2 , OH radicals Grune et al. (2010)
↓vitamin A oxidation
Ascorbic acid ↓ H2O2,OH, ↓ O2 radicals; neutralizes oxidants obtained from stimulated neutrophils Traber and Stevens (2011)
↑ vitamin E
Non-enzymatic Carotenoids restrict the propagation of free radical chain reaction Jomova and Valko (2013)
Non-enzymatic Flavonoids stabilizes the ROS Panche et al. (2016)
Non-enzymatic Melatonin detoxify reactive nitrogen and oxygen species and raises the activity of the antioxidant defense system Hacişevki and Baba (2018)
Non-enzymatic Thiol antioxidants (lipoic acid, thioredoxin, and glutathione) thiol, compounds showed antioxidant activity due to the presence of sulphur atoms Flora (2009)
4.2.1.1 Vitamin E

Vitamin E (alpha-tocopherol) is considered to be an important antioxidant that involves in the chain-breaking process in the case of humans. Vitamin E is present within the cell membrane to interrupt the peroxidation of lipid and also play a major role in the modulation of cell signaling pathways that are dependent on reactive oxygen intermediates (ROI). They also can directly scavenge the reactive species, including OH, O2 •-, and 1O2 (Traber and Atkinson, 2007). Vitamin E also plays a potent role in decreasing the cases of cancer. It functions by donating the hydrogen atom to fatty peroxyl radicals and disrupting the lipid peroxidation process. It also has the potential to make a reaction with two peroxyl radicals as shown below:

αtocopherol+LOOVitEαtocopherol.+LOOH
αtocopherol+LOOLOOαtocopherol
αtocopherolthe+LOO.VitELOOαtocopherol

The vitamin E synthesized in Equation assumes to have a resonance-stabilized conformation which allows this vitamin to react with other peroxyl radicals to form a stable adduct, LOO-α-tocopherol. Alpha-tocopherol restricts the generation of new free radical whereas gamma-tocopherol neutralizes or trap the existing reactive species. OS has been associated with various possible diseases but rather vitamin E helps to delay or prevent the chronic ailments associated with free reactive molecules (Traber and Stevens, 2011).

4.2.1.2 Vitamin C

Uric acid, cysteine, glutathione, and vitamin C (ascorbic acid) work as a hydrophilic scavenger of oxygen radicals (Lobo et al., 2010). Natural ascorbate restricts the carcinogenic process of various nitroso compounds, fed to animals by converting them to an inactive form. This vitamin C can be utilized to detoxify the different organic compounds in vivo by a simple reduction process (Combet et al., 2007). Ascorbic acid is a potent scavenger and reducing agent of reactive species in the biological system. It is included in the first line of ddefenceof antioxidants, protecting the proteins and lipid membrane from damage (Pehlivan, 2017). Due to its water-soluble nature, vitamin C can work both outside and inside the cells and can neutralize the free reactive species to avoid any damage. This vitamin works as an excellent source of electrons for the reactive species that are finding out an electron to acquire their stability. They can donate electrons to those free radicals and scavenge their reactivity (Padayatty and Levine, 2016). Cysteine is the physiological precursor of glutathione (GSH) and has been known widely for its protective function against mutagenesis and radiation. Vitamin C or ascorbic acid reacts with singlet oxygen (1O2), peroxyl radical (ROO•), hydrogen peroxide (H2O2), and hydroxyl radical (OH), to form the dehydroascorbate A) and semidehydroascorbate radical (A‾) as shown in equation below (Phaniendra et al., 2015).

AH+OHVitCH2O+A
AH+1O2+H+VitCH2O2+A
AH+ROOVitCRH+A
AH+H2O2+H+VitC2H2O+A
4.2.1.3 Vitamin A

Vitamin A and ß-carotene are important antioxidants as they interfere with the process of peroxidation. ß-Carotene is also found to be useful in decreasing the incidence of cancer. Two major functions of ß-carotene are the ability to neutralize and trap certain organic free radicals and to deactivate the oxygen radicals present in exciting form, produced as a byproduct of metabolic reactions (Fiedor and Burda, 2014). The consistent and strongest conformation regarding the protective effect of large consumption of carotene-rich food comes from studies of the esophagus and lung cancer (Patel et al., 2018). ß-Carotene act as an antioxidant under low oxygen tension and can also act as a prooxidant under more oxidizing and high concentration level in the case of smokers (Tapiero et al., 2004).

The reaction of ß-carotene (CAR) with lipid peroxyl radicals (LOO•) to form various carbon-centred radicals such as (LOO)2-CAR-(OOL)2) (LOO)2-CAR-OOL•, LOO-CAR-OOL, and LOO-CAR• is represented in equation.

CAR+LOOβcaroLOOCAR
LOOCAR+LOOβcaroLOOCAROOL
LOOCAROOL+LOO2βcaroLOO2CAROOL
LOO2CAROOL+LOOβcaroLOO2CAROOL2

A sole molecule of ß-carotene is determined to eliminate around 1,000 of singlet oxygen with the help of a physical mechanism which involves the transfer of energy before it gets oxidized and loses its antioxidant activity (Tan et al., 2018). The rate of ß-carotene oxidation is dependent upon the partial pressure of oxygen. The carbon-centred radicals get resonance stabilized when the oxygen pressure is lowered. The balanced reaction rapidly shifts to the left side to lower the concentration of peroxyl radicals (LOO•), and the autooxidation rate of ß-carotene get reduced (Iannone et al., 1998). The ß-carotene activity towards peroxyl radicals and the stability of other carbon-centred radicals are the two main features that provide the carotene molecule with its antioxidant properties (Fiedor and Burda, 2014).

4.2.1.4 Selenium

Selenium is a natural element which has gained focus due to its potential to decrease the process of carcinogenesis. The antioxidant activity of selenium concerning vitamin C was studied broadly (Tan et al., 2018). Deficiency of selenium results in the consequent cellular and tissue damage raised peroxidation of lipids and leads to the formation of free radicals. Damage caused to unsaturated fatty acids in the subcellular membrane by peroxidation reaction can be reduced by Se and vitamin E (Mourente et al., 2007). The metabolisms of Se and vitamin E are interrelated and Se plays a major role in vitamin E storage.

4.2.2 Natural antioxidants

4.2.2.1 Phenolic compounds

Phenolic compounds are a heterogenous group of phytocompounds that are broadly spread in the plant kingdom (Chaudhary et al., 2023). Flavonoid belongs to a class of naturally occurring polyphenolic compounds and they provide different colors to leaves, fruit, and flower (Chaudhary et al., 2023). Flavonoids are further divided into the following classes: anthocyanidins, flavones, flavonols, flavanones, and flavonols. Among the classes, variations are based on the arrangement and number of hydroxyl groups, and glycosylation or alkylation of these groups. The broad varieties of flavonoids and the greatest difference in their content make it difficult to determine the daily intake estimate of flavonoids (Panche et al., 2016). Phenolics and flavonoids act as an antioxidant through several pathways The most potent one is likely to be by scavenging the free radicals in which polyphenols carried out the breakdown of several free radical chain reactions (Kaurinovic and Vastag, 2019). For a molecule to act as an antioxidant, it must fulfil the two criteria.

  • (i) at low concentrations, it can prevent the oxidation of the substrate

  • (ii) the radical generated on the polyphenols must be stable enough so that it can prevent itself from acting as a chain-propagating radical (Dangles, 2012).

This stabilization is usually through intramolecular hydrogen bonding and delocalization or by reaction with other lipid radicals and further oxidation. A large number of investigations have been done on the structure-antioxidant activity relationship of flavonoids (Table 2). Some of the common ones are flavanol, flavonoid, and quercetin which are abundant in onion, broccoli, and apple; catechin, another flavanol present in different tea and fruits; naringenin, the major flavanone in grapefruit; glycitein, genistein, and daidzein are the major isoflavanones in soybean; and cyanogen glycosides are abundant in blackberry, raspberry, and black currant.

4.2.2.2 Curcumin

Curcumins target free radicals through various mechanisms. It can restrict the activation of ROS-producing enzymes such as xanthine oxidase/hydrogenase, and cyclooxygenase/lipoxygenase, it can modulate the activity of SOD, catalase, and GSH enzymes for the neutralization reaction, and it can also have the ability to scavenge the reactive nitrogen and oxygen species. Additionally, curcumin is a lipophilic molecule, which makes it useful in the scavenging of peroxyl radicals. Therefore, like vitamin E, curcumin is also utilized as a chain-breaking natural agent.

4.2.2.3 Tannins

Tannin is the common name for phenolic molecules that are used for tanning leather and the precipitation of gelatin from solution. They are further categorized into the condensed form of proanthocyanidins, in which the main structural unit is the phenolic flavan-3-ol nucleus and hexahydroxydiphenoyl and galloyl ester and their derivatives, ellagitannins and gallotannins (Clifford and Scalbert, 2000). The two main groups of phenolic acids are hydroxycinnamic acid and hydroxybenzoic acid, both of which are obtained from cinnamic acid and benzoid molecule, respectively (Kumar and Goel, 2019). These phenolic acids contain benzoic acid derivatives such as cinnamic acid derivatives (ferulic, caffeic and coumaric acid) and gallic acid. Caffeic acid is majorly found in vegetables and fruits, most commonly esterified with quinic acid as in chlorogenic acid, the main phenolic in coffee. Another common phenolic acid is ferulic acid which is esterified with hemicellulose and present in cereals (Dai and Mumper, 2010).

4.2.2.4 Phenolic acids
4.2.2.4.1 Caffeic acid

Caffeic acid is produced by different plant species and is found to be available in various food products such as tea, wine, and coffee and other medicines such as propolis. Phenolic acid and its derivatives have anticarcinogenic, anti-inflammatory, and antioxidant activities. In vivo and in vitro investigations have determined the anticarcinogenic property of this agent in the case of hepatocarcinoma, which is considered to be a highly aggressive form of cancer, responsible for the large rate of mortality across the globe. The anticancer activity of this compound is related to its pro-oxidant and antioxidant capacity due to its complex structure including double bond in the carbonic chain, the position and number of OH group and free phenolic hydroxyl in the catechol group, respectively (Kiokias et al., 2020). The pharmacokinetic investigation determined that this compound is being hydrolyzed by the microbial colonies and metabolized in the mucosa of the intestine through phase II enzymes, submitted to methylation and conjugation process, forming methylated, glucuronic, and sulphated conjugates by the action of o-methyltransferase, UDP-glucosyltransferases, and sulfotransferases, respectively (Monteiro Espindola et al., 2019). The transmembrane flux of this compound in intestinal cells occurs via the active transport carried out by the carriers of monocarboxylic acid. It can act by suppressing the expression of MMP-9 and MMP-2, blocking STATs, reducing the angiogenesis of tumor cells, inducing the oxidation of DNA of tumor cells, and preventing the generation of ROS (Monteiro Espindola et al., 2019).

4.2.2.4.2 Gallic acid

Gallic acid exerts its antioxidant effects by modulating the pro-oxidant/anti-oxidant balance. It can induce apoptosis, autophagy, and cell cycle arrest via activating the ROS generation and caspase pathway. Additionally, they can restrict metastasis and invasion by reducing the activity and expression of matrix metalloproteinase (Kahkeshani et al., 2019).

4.2.2.4.3 Ferulic acid

The antioxidant activity of ferulic acid is very complex. It is majorly based on the restriction of RNS and ROS formation and neutralization of free radicals. This compound also acts as a hydrogen donor; donating atoms directly to free radicals. This acid is found to be important for the protection of lipidic acids in the cell membrane from the unwanted autoxidation process. As a secondary compound, ferulic acid and its derivatives can bind with copper and iron and avoid the generation of toxic hydroxyl radicals, which direct cellular damage (Zduńska et al., 2018).

4.2.2.4.4 Carnosic acid

This acid is extracted from Rosmarinus and Salvia species and reported with various antioxidant and functional properties. It is most commonly used in the pharmaceuticals and cosmetic sector. In vitro experimental investigation, it has been observed that the administration of 20 μg/mL of Car A resulted in the cure of breast cancer via the activation of apoptotic and antioxidant genes (Einbond et al., 2012).

4.2.2.4.5 p-Coumaric acid

This acid is most commonly found in cereals, vegetables and fruits. It acts as a potent antioxidant and scavenges free radicals and reactive species. p-coumaric acid is a phenolic acid and is a hydroxyl derivative of cinnamic acid. It reduces the prefigure oxidation of low-density lipoprotein and decreases the risk of stomach cancer (Kiliç and Yeşiloğlu, 2013).

4.2.2.5 Stilbenes

Stilbenes comprise two phenyl moieties which are connected by the methylene bridge of two carbon atoms. The availability of stilbenes in an organism’s diet is very low. Majorly these compounds act as an antifungal phytoalexin, the compound which is synthesized in response to injury. One of the widely known stilbenes is resveratrol, found majorly in grapes. Products of red wine and grapes contain a significant amount of resveratrol, respectively (Rocha-González et al., 2008).

4.2.2.6 Lignans

Lignans are the phenolic compounds and have 2,3-dibenzylbutane structures that is resulted from the dimerization of two cinnamic acid residues; lignans such as secoisolariciresinol are considered phytoestrogen. The increasing interest in the beneficial effect of phenolic compounds has resulted in the development of such diets that are rich in vegetables and fruits and provide protection against cancer and cardiovascular diseases. The linseed act as a source which provides secoisolariciresinol (up to 3.7 g/kg dry weight) and a low amount of mataresinol, respectively (Milder et al., 2005).

4.2.2.7 Alkaloids

Erythroxylum cuneatum, a tropical flowering plant of the Erythroxylaceae family utilized in Thailand and Malaysia as traditional medicine. The alkaloid extract of E. cuneatum leaf possesses both anti-inflammatory and antioxidative activity suggesting its role in the development of anti-inflammatory and antioxidant drugs (Li S et al., 2015). Two isoquinoline alkaloids kareemine 2) and iraqiine 1), along with N-methylouregidione 7), atherospermidine 6), O-methylmoschatoline 5), kinabaline 4), and muniranine 3) were isolated from the dichloromethane extract of Alphonsea cylindrica bark. Compounds 4, 3, and 1 possess higher DPPH scavenging activity (Obaid Aldulaimi et al., 2019). The antioxidant activity of alkaloid boldine and Peumus boldus extract was reported against Fe(II)-citrate-induced damage in rat liver mitochondria in vitro (Klimaczewski et al., 2014). Stephania rotunda Lour., a Cambodian wild plant utilized in traditional medicine and food for the treatment of fever. The antioxidant activity of fangchinoline and cepharanthine was reported from Stephania rotunda by in vitro assays (Gülçin et al., 2010). The results determined an effective radical scavenging and antioxidant activity of fangchinoline and cepharanthine. Five new alkaloids (1–5) along with two new phenanthrene and three aporphine alkaloids, in total 10 (6–15) compounds were isolated from the roots of Stephania tetandra. Based on electronic circular dichroism, single crystal X-ray, and spectroscopic analysis, compound 13, and 7–10 exhibited great antioxidant activities (Wang R et al., 2020).

4.2.2.8 Terpenoids

Terpenes play an important role in the metabolic processes of a broad range of microorganisms, plants, and animals in which they are formed Naturally, terpenoids can be utilized for different purposes including as key agents in metabolic processes, signaling, and defense (Baccouri and Rajhi, 2021). These terpenes have had applications in medicine, cosmetics, and perfumery for thousands of years and are still procured from different plants for the above-mentioned uses. The antioxidant activities of terpenes may explain their capacity to adjust the neural signal transmission, immunological effects, and inflammation. They protect against oxidative stress situations including ageing, diabetes, neurodegenerative, cardiovascular disease, cancer, liver, and renal mechanisms (Baccouri and Rajhi, 2021). Bourgou et al. (2012) reported the antioxidant activity of isolated terpenoids from Tunisian Nigella sativa L. essential oils and also their ability in restricting the production of nitric oxides. The chemical characterization and antioxidant activity of essential oils isolated from Euphorbia heterophylla L. (Elshamy et al., 2019) and their allelopathic potential were reported against Cenchrus echinatus L. Sesquiterpenes-rich essential oil isolated from the above parts of Pulicaria somalensis showed great antioxidant activity and allelopathic effect against weeds (Assaeed et al., 2020). In a study to determine the antitumor effects of terpenoids, it was found that paclitaxel, geraniol, and perillyl alcohol are the terpenoids with better anticancer activities (Yang et al., 2020). The anti-inflammatory activity of paeoniflorin and its derivatives, 4-O-methylbenzoyl paeoniflorin, 4-O-methyl paeoniflorin, and other monoterpenes was reported (Bi et al., 2017). The results reported that most of these monoterpenes can inhibit the production of tumor necrosis factor-alpha (TNF-α), interleukins-6 (IL-6), and inflammatory factor nitric oxide (NO) induced by lipopolysaccharides (LPs).

5 Antioxidants: Mode of action and molecular mechanisms

The mode of action of antioxidants can be explained by the following routes.

5.1 Preventive antioxidants

ROS such as OH, O2•, and H2O2 are generated irreversibly during the process of metabolism. Other free radicals such as ROOH, and organic hydroperoxide are generated by the reaction of radicals with the cellular components such as nucleobases and lipids. The RO, ROO. peroxyl, and alkoxy radicals are oxygen centered organic types of radicals. Lipids form take part in the peroxidation reaction of lipids. They are generated in the presence of oxygen by abstraction of hydrogen and addition of radicals to double bonds. Hypochlorous acid or HOCl are generated from hydrogen peroxide in the presence of myeloperoxidase. They are highly reactive and readily oxidized protein constituents such as methionine, amino groups, and thiol groups. Peroxynitrite radical is generated in a reaction of superoxide with nitric oxide. The protonation reaction results in the formation of peroxynitrous acid which undergo hemolytic cleavage to form nitrogen dioxide and hydroxyl radicals (Lobo et al., 2010). Therefore, various methods have been applied to decrease the damage caused by oxidative stress. Endogenous antioxidant enzymes which are generated inside the cells work as a protective mechanism against reactive free species. Heme oxygenase, reductase, thioredoxin, GST, GR, GPx, CAT and SOD are the most vital antioxidant enzymes. The SOD carried out the conversion of O2•– into H2O2, which is further converted into H2O with the help of the Fenton reaction, GPx, and CAT. Thus, there is a conversion of toxic species to the harmless product. Peroxides generated during the process of metabolism, get eliminated by GPx and GST. GRd is found to be useful to maintain the equivalent of oxidized glutathione (GSSG) and GSH, as the ratio of GSSG/GSH is an indicator of oxidative stress. So, GRd functions by raising the concentration of GSH, which is required for the maintenance of oxide-redox conditions in a living organism. The GPx is available throughout the cells whereas CAT is restricted to the peroxisome. The brain is very sensitive towards the damage caused by free radicals so; it contains 7 times more concentration of GPx than the CAT. The greatest level of CAT is found in erythrocytes, kidneys, and the liver, where it decomposes most of the hydrogen peroxide (Aziz et al., 2019).

5.2 Free radical scavengers

The utilization and consumption of oxygen in physiological processes result in the production of ROS. The production of energy in mitochondria is dependent upon the metabolism of oxygen since oxygen gets reduced to water. During the transfer of electrons through a pathway, incomplete reduction of oxygen can result in the production of highly damaging and reactive ROS, such as hydroxyl radical, hydrogen peroxide, singlet oxygen and superoxide radicals The toxicity of superoxide radicals can be diminished with the help of metalloenzyme SOD which catalyzes the reduction of O2 •- to O2 and H2O2. Other antioxidant agents such as green tea extract are also capable of reducing the damage resulting from superoxide radicals. Hydroxyl radicals are generally formed from the Cu+/H2O2 or Fe2+ Fenton reaction system via incubation of H2O2 and FeSO4 in an aqueous solution. These radicals are found to be toxic to macromolecules such as proteins, lipids, and DNA. The application of various polyphenol and polyene from different vegetables and fruits protect against the damaging effect of hydroxyl radicals (Lipinski, 2011). Large numbers of metals are responsible for inducing carcinogenicity and toxicity in the animal body. An excessive amount of iron in the body leads to cancer, vascular diseases and other neurological complications. Copper at higher concentrations is known to result in metastasis. The complexes of cobalt ion led to the production of ROS which cause heart complications. Research showed that Se can chelate copper ions efficiently and prevent the damage caused to DNA by hydroxyl radicals. The component of red wine binds to high-density lipoprotein (HDL) and low-density lipoprotein (LDL) and protect lipoproteins from metal-independent and meta-dependent lipid and protein oxidation (Ivanov et al., 2001). According to some studies, melanoidin possessed better scavenging and metal-ion chelating activity which were due to its molecular weight (Wu et al., 2021). It has been determined that the major source of free radicals in diverse pathological and physiological circumstances is related to the enzyme number. The enzymes that lead the generation of superoxide include NADPH-dependent oxidase, cyclooxygenase, lipoxygenase, and xanthine oxidase. The production of hydrogen peroxide is catalyzed by the superoxide dismutase enzyme. Various enzymes of peroxisomes such as D-aspartate oxidase, xanthine oxidase, urate oxidase, D-amino acid oxidase and acyl CoA oxidase direct the production of different ROS. Many natural agents have revealed their potential to restrict the enzymes that direct the generation of free radicals as well as in the development of novel therapeutics agents against oxidative stress-induced diseases (Phaniendra et al., 2015). Plant alkaloids such as berberine carried out the inhibition of NADPH oxidase activity via reducing the mRNA expression of gp91phox in macrophages. Similar results were obtained by the treatment with dihomo-γ-linolenic (ω-6) acid, ellagic acid (from nuts and fruits), and 3-(4′-hydroxyl-3′,5′-dimethoxyphenyl) propionic acid (HDMPPA) (from kimchi), (Maraldi, 2013). Eugenol obtained from Ocimum sanctum showed 97% inhibition in the activity of cyclooxygenase at 1000-microM concentration (Kelm et al., 2000).

5.3 Prevention of lipid peroxidation

Lipid peroxidation is damaging due to the production of products which leads to the spread of free radical reactions. The potent function of lipids in the cellular system emphasizes the need to understand the consequences and mechanism of lipid peroxidation in the human body. Polyunsaturated fatty acids (PUFAs) are utilized as the substrate for the peroxidation of lipids due to the presence of active bis-allylic methylene groups. The hydrogen-carbon bonds on these methylene units have very low bond-dissociation energy, making the hydrogen atom to be abstracted easily in the radical reactions (Davies and Guo, 2014). It has been determined that the a-tocopherol is the most suitable antioxidant and protect the membrane from oxidation by reacting with the various lipid radicals generated in the peroxidation chain reaction of lipid. It carried out the removal of free radical intermediates and prevents the continuation of the propagation reaction (Mostafa Abd El-Aal, 2012). Antioxidants such as t-butyl hydroxy anisole (BHA), t-butylhydroxyl toluene (BHT), and vitamin E inhibited the Fe2+/ascorbate-induced peroxidation of lipids in the liver microsome of rats (Reddy and Lokesh, 1992). The natural agent, rosmarinic acid spontaneously penetrates the cell membrane to inhibit the peroxidation of lipids in situ as reported by Fadel et al. (2011).

5.4 Prevention of DNA damage

Oxidative stress is the major reason behind the majority of DNA damage in the case of human beings. Various factors are responsible for the production of free radicals and ROS. The major factors are smoking, junk foods/fried foods, restless life, and lifestyle change (Kaur et al., 2019). Antioxidant agents include external antioxidants and internal antioxidants that can be consumed through a diet to fulfil the natural need of the human body. These agents can scavenge free radicals and prevent further damage (Jamshidi et al., 2018). The fraction obtained from normal and transformed roots of Rhaponticum carthamoides provides DNA repair and antioxidant effect against oxidative stress-induced DNA damage in Chinese hamster ovary (CHO cells); (Skala et al., 2016). The methanolic fraction of Tamarind indica, Adhatoda vasica, Centella asiatica, Pseudomugii furcatus, and Kocuria indica protect against DNA damage. Trans-resveratrol and p-coumaric acid extracted from the ethanolic fraction of germinated peanut also protect against DNA damage (Limmongkon et al., 2019).

5.5 Prevention of protein modification

The oxidation of protein can be induced by several radical species such as hydroperoxyl, alkoxyl, peroxyl, •OH, O2 •-, and by some non-radical species as well like OONO, singlet oxygen, HOCl, O3, and H2O2. The reactive species oxidize the different types of amino acids present in the protein and result in the generation of the protein-protein cross linkage which further results in the denaturation, loss of protein functioning, loss of transport protein and receptor functioning, and loss of enzymatic activity. Hydroxyl radicals are reactive, they can further react with both inorganic and organic molecules like carbohydrates, lipids, proteins, and DNA and results in severe damage to cells (Phaniendra et al., 2015). Both biliverdin and bilirubin exhibited greater antioxidant activity than alpha-tocopherol against peroxynitrite and peroxyl-radical-induced protein oxidation in the brain microsome of rats in vitro (Mancuso et al., 2012).

5.6 Antioxidants’ protective effect against cancer

Chemoprevention of cancer is defined as the reverse process or inhibition of carcinogenesis by the administration of synthetic and natural agents as shown in Table 3. These agents have helped to understand the molecular and cellular levels of carcinogenesis. The chemopreventive agents can be divided into three wide categories.

  • (i) Those which prevent the generation of procarcinogens from the precursor components e.g., Vit. C, which avoids nitroso compounds formation (Landis-Piwowar and Iyer, 2014).

  • (ii) Blocking agents: These prevent the cancer casing compounds from interacting with the cellular target e.g., flavones, isothiocyanates, and phenols. Further, blocking agents are sub-categorized into three major categories: those which restrict the activation of carcinogen to its carcinogenic form; those which induce the enzyme system capable of carcinogen detoxification, and those which can react with cancer-causing species and prevent their reaction with the cellular targets (Steward and Brown, 2013; Landis-Piwowar and Iyer, 2014).

  • (iii) Suppressing agents: These restrict carcinogenesis by suppressing their activity e.g., protease inhibitors, sea salt, and retinoic acid (Usman et al., 2022).

TABLE 3.

Role of antioxidants in the chemoprevention of other diseases.

Antioxidants Diseases Results/potential mechanism References
Pre-clinical studies
Resveratrol Heart disease ↓ LDL,↓myocardial infarction risk, ↓coronary heart diseases Conti et al. (2016)
Curcumin Aging ↓ skin aging, ↓inflammation, ↓free radicals Panahi et al. (2019)
Alzheimer’s disease ↑Aβ disaggregation Kamat et al. (2016)
Lupeol Cataract ↑protection against nuclear opacity formation Tewari et al. (2019)
Epigallocatechin-gallate Alzheimer’s disease ↓Aβ, ↓amyloidosis Kamat et al. (2016)
Huntington’s disease ↓toxicity of mHTT and decline in motor function
NAC, Beta-carotene, vitamin E Parkinson disease ↓MPTP-directed neurotoxicity
↓loss of neurons
Amygdaline Neurodegenerative disease ↑Nrf2, ↓KEAP1, ↑antioxidant system in SH-SY5Y, N2a cells Singh et al. (2021)
Hesperetin ↑ HO-1, ↑Nrf2 expression in BV2, HT22 cells
Quercetin ↓neuroinflammation, ↑Nrf2/HO-1, ↓NF-kB
Tenuigenin ↓neuroinflammation, ↑Keap1-Nrf2
Delphinidin-3-glucoside Coronary heart disease and Ischemia-reperfusion injury ↓caspase-3, ↓NOX2/NOX4 Chang et al. (2020)
↓ROS, ↑autophagy, ↑AMPK/SIRT1
Berberine Hypertension ↑ AMPK/mTOR
Ferulic acid Heart failure ↑PI3K/Akt/mTOR, ↓ROS
Gypenoside Acute myocardial infarction ↑SOD, ↓free radicals
Paeonol Arrhythmia and coronary heart disease ↑SOD, ↓free radicals, ↓LPO
p-Coumaric acid Rheumatoid arthritis ↓TNF-α Khanna et al. (2017)
Genistein Rheumatoid arthritis maintained a balance between Th2 and Th1
↓IL-4, ↓IFN-γ, ↓inflammation
Curcumin Rheumatoid arthritis ↓IL-6, ↓IL-1 in RA patient-derived fibroblast-like synoviocytes
EGCG Rheumatoid arthritis ↓Mcl-1, ↑apoptosis
↓MMP-3, ↓MMP-2, ↓MMP-1
↓cartilage and bone destruction
Catechin Cardiovascular disease hypocholesterolemic effect Velayutham et al. (2008)
↓cholesterol esters, ↓low-density lipoprotein, ↓ plasma total cholestrol
Lycopene Sexual maturation ↑motility of sperm in broilers Adewoyin et al. (2017)
Marjoram ↑ sperm and spermatogenic cells in the high fat diet
↑degenerative changes in seminiferous tubules
Echinacoside ↓sperm damage which supports its capacity of profertility in SD rats, TM3, and LC-540 cells Noh et al. (2020)
Soy isoflavones ↑sensitivity of insulin, ↑small leucine-rich proteoglycan
Berberine-Rich fraction ↑quality of sperm, ↓inflammation, ↓oxidative stress related with male infertility Saleh et al. (2018)
Zerumbone Diabetes nephropathy ↓TGF-β1, ↓MCP-1, ↓fibronectin, ↓intercellular adhesion molecule-1 in the DN Al-Waili et al. (2017)
Curcumin Inhibits the expression of inflammatory genes by reversing caveolin Tyr phosphorylation that influenced the activation of Toll-like receptor 4
Allicin ↓morphological alterations induced by diabetes in the kidney
↓triglyceride, ↓Scr, ↓BUN, ↓BGL,↓urine albumin
↓p-ERK1/2, ↓TGF-β1, ↓collagen I
Rosmarinic acid protective role against DN
↓ CTGF
Quercetin, alpha-tocopherol, nifedipine, tetracycline Ulcerogenesis anti-ulcer effects in rat Suzuki et al. (1998)
Sesamol ↓gastric mucosal myeloperoxidase Elseweidy (2011)
↓mucosal proinflammatory cytokines
↓oxide production, ↓lipid peroxidation, ↓nitric oxide
Hesperidin Depression ↓hyperglycaemia, ↑BDNF, ↑neurogenesis Hritcu et al. (2017)
↑ brain levels of monoamines in forced swimming test (FST) depression model
Naringenin ↑glucocorticoid receptor (GR), ↑norepinephrine, ↑5-HT in tail suspension (TST) and open field test (OST)
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose (PGG) Renal injury ↓excretion of calcium oxalate crystal Deepika et al. (2013)
↓ROS in EG-directed human primary renal epithelial cells (HRCs)
Taurine ↓renal injury caused by oxidative stress, ↑GDH, ↑SOD
↓injury of mitochondrial membrane with lesser deposition of crystal in the kidney
Lutein Ischemic stroke ↓deleterious cerebral I/R outcomes and can be utilized as a treatment for stroke patients Bahonar et al. (2017)
Essential oils from Pinus roxburghii Tuberculosis pollen dust and resin water used to treat tuberculosis Verma et al. (2020)
Clinical studies
Resveratrol Superior thyroid artery from 59 old patients suffered with dyslipidemia and hypertension ↓ endothelial dysfunction via modulating the metabolism of nitric oxide and attenuation directed by vascular oxidative stress Conti et al. (2016)
Curcumin Central arterial compliance and arterial endothelial function in 32 post-menopausal women ↑improved the endothelial function Akazawa et al. (2013)
Epigallocatechin-gallate Multiple sclerosis in obese/overweight males ↑postprandial lipid oxidation that fuels the energy metabolism of muscles Thielecke et al. (2010)
Quercetin Hyperlipidemia in 400 patients ↓ total cholesterol, ↓triglycerides, ↓low-density lipoprotein, ↑increased high-density lipoprotein Talirevic and Sehovic (2012)
Type II diabetes mellitus in 24 patients ↓postprandial hyperglycemia within 30 min Yi et al. (2021)
Genistein Cardioprotective effect in 60 postmenopausal women ↓insulin level Crisafulli et al. (2005)
↓serum glucose level
↓deposition of fat in the heart and the blood vessels
Berberine Type II diabetes in 116 patients ↓triglycerides Cicero and Sibel (2009)
↓ low-density lipoprotein cholesterol
Lycopene 20 patients with signs of gingivitis ↓gingivitis Story et al. (2010)
↓index of bleeding
17 asthmatic individuals reduced influx of neutrophils to airways
↓ activity of neutrophil elastase that may improve the function of lungs in asthmatic individuals
Vitamin E 2,102 individuals with the serum concentration of inflammatory cytokines ↓inflammatory cytokines Asbaghi et al. (2020)
↓TNF-α, ↓CRP, ↓IL-6
Soy isoflavones Bone health maintenance trial with 26 individuals attenuated the bone resorption at the level of the femoral neck and lumbar spine Gómez-Zorita et al. (2020)
1,307 women at cardiovascular risk ↓triglycerides
↓total cholesterol concentration
↓oxidative stress markers
↓cardiovascular diseases risk

Abbreviations and symbols: ↑increase, ↓decrease, CRP: C-reactive protein, LDL: Low-density lipoprotein; mHTT: mutant huntingtin; MPTP: 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine; Nrf2: Nuclear factor erythroid 2-related factor 2; KEAP: Kelch-like ECH-associated protein; HO-1: Heme oxygenase-1; SH-SY5Y: neuroblastoma cell line; N2a: Neural crest-dericed cell line; BV-2: microglial cells; HT22: Hippocampal cell line; NOX2: NADPH, oxidase 2; NOX4: NADPH, oxidase 4; ROS: reactive oxygen species; AMPK: AMP-activated protein kinase; SIRT1: Sirtuin 1; mTOR: rapamycin; PI3K: Phosphoinositine 3-kinase; SOD: superoxide dismutase; TNF-α- Tumor necrosis factor alpha; Th2: T helper 2; Th1: T helper 1; IL-4: Interleukin 4; IFN-γ: interferon gamma; IL-6: Interleukin 6; IL-1; Interleukin 1; RA: rheumatoid arthritis; Mcl-1″ myceloid cell leukemia-1; MMP-3: Matrix metalloproteinase-3; MMP-2: Matrix metalloproteinase-2; MMP-1: Matrix metalloproteinase-1; TM3: leydig cells; LC-540: Cellosaurus cell line; TGF-β1: Transforming growth factor beta; MCP-1: Monocyte chemoattractant protein-1; DN: diabetes neuropathy; BUN: blodd urea nitrogen; BGL: blood glucose level; ERK1/2: Extracellular signal-regulated kinase ½; TGF-β1: Transforming growth factor-beta; CTGF: connective tissue growth factor; BDNF: Brain-derived neurotrophic factor; GDH: glutamate dehydrogenase.

Antioxidant defence such as the enzymes involved in the DNA damage repair cannot counteract all the oxidants and this results in damage which may lead to mutation and further contribute to carcinogenesis. Dietary antioxidants are ubiquitous and protect plants against oxidative assault and this property of them may be found to be useful in humans in terms of decreasing the risk of cancer. ROS are involved at all stages of tumor development, consequently, dietary agents are found to be protected throughout the stages of carcinogenesis. Citrus fruit is also reported to be beneficial in about 65% of investigational studies. The tumour-inhibitory effects imparted by these plant foods are due to the presence of various antioxidants such as carotenoids, polyphenolics, selenium, vitamin C, vitamin E, and provitamin A, respectively. It is determined that various constituents contribute to the overall protective effect (Bouayed and Bohn, 2010). Lung tumor risk has been reported to be decreased by the consumption of high vegetables and fruits in both retrospective epidemiological and prospective studies (Dela Cruz et al., 2011). Efficient inactivation of both endogenous and xenobiotics toxins results in the restriction of several cytotoxic events, and in the prevention of cellular integrity, which may lead to various diseases. The equilibrium between the phase II detoxifying enzyme and phase I carcinogen-activating enzyme is important to determine an individual’s risk of cancer disease (Wilkinson and Clapper, 1997). The contribution of various families of enzymes such as conjugation catalyzing transferase, hydrolases, peroxidases, reductases, dehydrogenases, and monooxygenases results in protection against different hazardous components like N-nitroso compounds, which are very different in their cellular defense mechanism. Some carcinogens act directly while others need activation (Rendic and Guengerich, 2012). The metabolism of the xenobiotic component is carried by many enzymes that are included in Phase II and I reactions (Jančová and Šiller, 2012). Phase I reactions include hydrolysis, reduction, hydroxylation, and oxidation, which results in water-soluble metabolites and further facilitate their excretion and conjugation. Cytochrome P450-dependent monooxygenase is the broadly studied phase I enzyme that is responsible for xenobiotic metabolism. These enzymes are encoded by the superfamily of CYP genes. In the NADPH monooxygenase system: P450 oxidoreductase transfer the electrons from NADPH to P450 and results in the formation of ferrocytochrome P450 which carried out molecular oxygen activation and one of the atoms of oxygen is added to the substrate molecule (Riddick et al., 2013). Other enzymes of phase I include: reductase, aromatase, dehydrogenase, monoamine oxidase, hydrolase, lipoxygenase, cyclooxygenase, and monooxygenase. The products of phase I reactions act as a substrate for the phase II enzymes but some of the xenobiotics are conjugated directly bypassing the metabolism of phase I. Cytochrome b5 is one of the competitive inhibitors of CytP450 phosphorylation by protein kinase. Thus, b5 has a key role in the activity of cytP450. Mixed function oxidase is the flavin comprising monooxygenase present in the ER and contains one FAD molecule. The endogenous substrate for this is cysteamine and it can oxidize the nucleophilic sulphur and nitrogen atom (Porter, 2002). Detoxification enzymes of phase II compete with the activating enzymes of phase I to restrict the generation of electrophiles and catalyze the conversion of these electrophilic molecules to inactivate conjugates, making them more soluble in water and more easily get excreted from the body. Some of the conjugating reactions are glutathione conjugation, sulfation, and glucuronidation, respectively (Hodges and Minich, 2015).

5.7 Antioxidant’s protective effects against other diseases

The consumption of antioxidants through vegetables and fruits that are determined to be the better source of antioxidants helping in the treatment of cardiovascular diseases. These antioxidants are also utilized in the prevention of neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease. Excessive production of reactive species leads to various pathological diseases such as ulcerogenic, depression, cardiovascular disorders, and rheumatoid arthritis. Antioxidants have been considered to play an important role in the prevention of these diseases. It has been found that antioxidants have a better potential for the treatment of problems related to sexual maturity, male infertility, and nephrolithiasis (Sindhi et al., 2013), (Table 3). Despite of various outcomes reported in vitro and in animal models, some studies are concentrated to humans and the results obtained are represented below in Table.

6 Therapeutic limitations

Natural antioxidant agents have many modes of action and can be useful in preventing diseases without side effects (Chaudhary and Janmeda, 2022b). The availability of antioxidants should be regulated by a prescription from a healthcare professional. Consumers should be advised about the health benefits of antioxidants and be encouraged to eat foods rich in vegetable oils, nuts, seeds, leafy vegetables and fresh fruits, which are the main sources of antioxidants. The main therapeutic limitation is the excessive consumption of antioxidant supplements that can cause side effects because in high concentrations antioxidants can act as pro-oxidants. There is also a significant difference between taking antioxidants from food and administering an isolated substance as a supplement. Many substances that show beneficial effects in the laboratory do not work when they are introduced into the human body. Many antioxidants do not have good bioavailability. The concentration of antioxidants such as polyphenols is sometimes so low in the blood that no significant effect is observed (Del Rio et al., 2013).

7 Conclusion and future perspectives

Free radicals-directed oxidative stress is known to be harmful to the health of a human being. Various experimental studies determine that free radicals contribute towards the progression and inhibition of various pathologies, ranging from cardiovascular disease to cancer. Antioxidants can counteract oxidative stress and mitigate all the effects on human health. These compounds gained a lot of attention from the field of biomedical research as they showed a better degree of efficacy in terms of the cure and prevention of various diseases. Synthetic antioxidants are found to be detrimental to the health of an organism. Therefore, the search for a non-toxic and natural compound with greater antioxidant activity has increased in the last few years. Through the literature survey, we can conclude that oxidative stress should be exploited as a tool for the treatment when and if we would be able to understand the fine-tuning of this phenomenon inside a living body. Newer approaches that utilise modern technology and collaborative research in combination with established conventional health practices can be used in near future for the improvement of health status, especially among individuals who do not have access to costlier therapeutic drugs.

Acknowledgments

We acknowledge the Bioinformatics Centre, Banasthali Vidyapith, supported by DBT and DST for providing computation and networking support through the FIST and CURIE programs at the Department of Bioscience and Biotechnology, Banasthali Vidyapith, Rajasthan.

Author contributions

Conceptualization and design were performed by PC, PJ, and JS-R; investigation, data curation, and writing were performed by PC, AD, and BM; validation, review and editing were performed by PJ, BY, AA, DC, and JS-R; supervision PJ, DC, and JS-R; All the authors contributed equally, read and approved the final manuscript. All authors have read and agreed to the published version of the manuscript.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Glossary

NO Nitric oxide
OH Hydroxyl
1O2 Singlet oxygen
AP-1 Activator protein
BHA Butylated hydroxyanisole
BHT Butylated hydrox ytoulene
BNDF Brain-derived neutrophic factor
CAFs Carcinoma associated fibroblast
CAT Catalase
COX2 Cyclooxygenase 2
Cu Copper
DNA Deoxyribonucleic acid
EMT Epithelial-mesenchymal transition
G6PD Glucose-6-phosphate dehydrogenase
GPx Glutathione peroxidase
GSH Glutathione
H2O2 Hydrogen peroxide
HCC Hepatocellular carcinoma
HDL High-density lipoprotein
HIF-1α Hypoxia-inducible factor
HOCl Hypochlorous acid
IL-6 Interleukin-6
iNOS inducible nitric oxide synthase
LDL Low-density lipoprotein
LOX Lipooxygenase
LPS Lipopolysaccharides
MAPK Mitogen-activated protein kinase
MMP9 Metalloproteinase 9
MPO Myeloperoxidase
NADPH Nicotinamide adenine dinucleotide phosphate
NO Nitric oxide
O2 .- Superoxide
ONOO Peroxynitrite
-OR Alkoxy
POAF Post-operative atrial fibrillation
PPAR-γ Peroxisome proliferated activated receptor gamma
PPP Pentose phosphate pathway
PTEN Phosphatase and tensin homolog
PUFAs Polyunsaturated fatty acids
RA Rheumatoid arthritis
RNA Ribonucleic acid
RNS Reactive nitrogen species
ROO Peroxyl
ROS Reactive oxygen species
SOD Superoxide dismutase
STATs Signal transducer and activator of transcription
TLR Toll-like receptor
TNF-α Tumor necrosis factor alpha
VEGF Vascular endothelial growth factor
XDO Xanthine dehydrogenase
XO Xanthine oxidase
Zn Zinc

References

  1. Adewoyin M., Ibrahim M., Roszaman R., Isa M. L. M., Alewi N. A. M., Rafa A. A. A., et al. (2017). Male infertility: The effect of natural antioxidants and phytocompounds on seminal oxidative stress. Dis 5 (1), 9. 10.3390/diseases5010009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akazawa N., Choi Y., Miyaki A., Tanabe Y., Sugawara J., Ajisaka R., et al. (2013). Effects of curcumin intake and aerobic exercise training on arterial compliance in postmenopausal women. Artery Res. 7 (1), 67–72. 10.1016/j.artres.2012.09.003 [DOI] [Google Scholar]
  3. Al-Waili N., Al-Waili H., Al-Waili T., Salom K. (2017). Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials. Redox Rep. 22 (3), 99–118. 10.1080/13510002.2017.1297885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ander B. P., Duapasquier C. M., Prociuk M. A., Pierce G. N. (2003). Polyunsaturated fatty acids and their effects on cardiovascular disease. Exp. Clin. Cardiol. 8 (4), 164–172. PMID: 19649216, PMCID: PMC2719153. [PMC free article] [PubMed] [Google Scholar]
  5. Ansar S., Tabassum H., Jamein N. A. (2013). Protective effect of butylated hydroxytoluene on ferric nitrilotriacetate induced hepatotoxicity and oxidative stress in mice. Hum. Exp. Toxicol. 32 (5), 513–521. 10.1177/0960327113477876 [DOI] [PubMed] [Google Scholar]
  6. Asbaghi O., Sadeghian M., Nazarian B., Sarreshtedari M., Mozaffari-Khosravi H., Maleki V., et al. (2020). The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: A systematic review and meta-analysis of randomized clinical trials. Sci. Rep. 10 (1), 17234. 10.1038/s41598-020-73741-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Assaeed A., Elshamy A., El Gendy A. E. N., Dar B., Al-Rowaily S., Abd-ElGawad A. (2020). Sesquiterpenes-rich essential oil from above ground parts of Pulicaria somalensis exhibited antioxidant activity and allelopathic effect on weeds. Agronomy 10 (3), 399. 10.3390/agronomy10030399 [DOI] [Google Scholar]
  8. Aziz M. A., Diab A. S., Mohammed A. A. (2019). “Antioxidant categories and mode of action,” in Antioxidants (IntechOpen; ). 10.5772/intechopen.83544 [DOI] [Google Scholar]
  9. Baccouri B., Rajhi I. (2021). “Potential antioxidant activity of terpenes,” in Terpenes and terpenoids-recent advances (IntechOpen.). 10.5772/intechopen.96638 [DOI] [Google Scholar]
  10. Bahonar A., Saadatnia M., Khorvash F., Maracy M., Khoshravi A. (2017). Carotenoids as potential antioxidant agents in stroke prevention: A systematic review. Int. J. Prev. Med. 8, 70. 10.4103/ijpvm.ijpvm_112_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bhatia M. (2017). Understanding toxicology: Mechanisms and applications. Cell. Biol. Toxicol. 33, 1–4. 10.1007/s10565-016-9363-8 [DOI] [PubMed] [Google Scholar]
  12. Bi X., Han L., Qu T., Mu Y., Guan P., Qu X., et al. (2017). Anti-inflammatory effects, SAR, and action mechanism of monoterpenoids from Radix paeoniae alba on LPS-stimulated RAW264.7 cells. Molecules 22 (5), 715. 10.3390/molecules22050715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bouayed J., Bohn T. (2010). Exogenous antioxidants-double edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell. Longev. 3 (4), 228–237. 10.4161/oxim.3.4.12858 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bourgou S., Pichette A., Lavoie S., Marzouk B., Legault J. (2012). Terpenoids isolated from Tunisian Nigella sativa L. essential oil with antioxidant activity and the ability to inhibit nitric oxide production. Flavour Frag. J. 27 (1), 69–74. 10.1002/ffj.2085 [DOI] [Google Scholar]
  15. Buettner G. R. (2011). Superoxide dismutase in redox biology: The roles of superoxide and hydrogen peroxide. Anticancer Agents Med. Chem. 11 (4), 341–346. 10.2174/187152011795677544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ceni E., Mello T., Galli A. (2014). Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J. Gastroenterol. 20 (47), 17756–17772. 10.3748/wjg.v20.i47.17756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chang X., Zhang T., Zhang W., Zhao Z., Sun J. (2020). Natural Drugs as a treatment strategy for cardiovascular disease through the regulation of oxidative stress. Oxid. Med. Cell. Longev. 2020, 1–20. 10.1155/2020/5430407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chaudhary P., Janmeda P. (2022a). Quantification of phytochemicals and in vitro antioxidant activities from various parts of Euphorbia neriifolia Linn. J. Appl. Biol. Biotechnol. 10 (02), 133–145. 10.7324/JABB.2022.100217 [DOI] [Google Scholar]
  19. Chaudhary P., Janmeda P. (2022b). Comparative pharmacognostical standardization of different parts of Euphorbia neriifolia Linn. Vegetos-Int. J. Plant Res. 36 (5), 210–221. 10.1007/s42535-022-00508-x [DOI] [Google Scholar]
  20. Chaudhary P., Singh D., Swapnil P., Meena M., Janmeda P. (2023). Euphorbia neriifolia (Indian spurge tree): A plant of multiple biological and pharmacological activities. Sustainability 15 (2), 1225. 10.3390/su15021225 [DOI] [Google Scholar]
  21. Chen H., Zhu B., Zhao L., Liu Y., Zhao F., Feng J., et al. (2018). Allicin inhibits proliferation and invasion in vitro and in vivo via SHP-1-mediated STAT3 signaling in cholangiocarcinoma. Cell. Physiol. biochem. 47 (2), 641–653. 10.1159/000490019 [DOI] [PubMed] [Google Scholar]
  22. Cheng J.-H., Hung C.-F., Yang S.-C., Wang J.-P., Won S.-J., Lin C.-N. (2008). Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2′,5′-dialkoxylchalcones as cancer chemopreventive agents. Bioorg. Med. Chem. 16 (15), 7270–7276. 10.1016/j.bmc.2008.06.031 [DOI] [PubMed] [Google Scholar]
  23. Cicero A. F., Sibel E. (2009). Metabolic and cardiovascular effects of berberine: From preclinical evidences to clinical trial results. Clin. Lipidol. 4 (5), 553–563. 10.2217/clp.09.41 [DOI] [Google Scholar]
  24. Clifford M. N., Scalbert A. (2000). Ellagitannins-Nature, Occurrence and dietary burden. J. Sci. Food Agric. 80 (7), 1118–1125. [DOI] [Google Scholar]
  25. Combet E., Paterson S., Iijima K., Winter J., Mullen W., Crozier A., et al. (2007). Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosation. Gut 56 (12), 1678–1684. 10.1136/gut.2007.128587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Conti V., Izzo V., Corbi G., Russomanno G., Manzo V., De Lise F., et al. (2016). Antioxidant supplementation in the treatment of aging-associated diseases. Front. Pharmacol. 7, 24. 10.3389/fphar.2016.00024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Coughlin S. S. (2018). Oxidative stress, antioxidants, physical activity, and the prevention of breast cancer initiation and progression. J. Environ. Health Sci. 4 (2), 55–57. 10.15436/2378-6841.18.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Crisafulli D., Marini H., Bitto A., Cucinotta D., Frisina N., Corrado F., et al. (2005). Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 12 (2), 186–192. 10.1097/00042192-200512020-00013 [DOI] [PubMed] [Google Scholar]
  29. D’Oria R., Schipani R., Leonardini A., Natalicchio A., Perrini S., Cignarelli A., et al. (2020). The role of oxidative stress in cardiac disease: From physiological response to injury factor. Oxid. Med. Cell. Longev. 2020, 1–29. 10.1155/2020/5732956 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Dai J., Mumper R. J. (2010). Plant phenolics: Extraction analysis and their antioxidant and anticancer properties. Molecules 15 (10), 7313–7352. 10.3390/molecules15107313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dangles O. (2012). Antioxidant activity of plant phenols: Chemical mechanisms and biological significance. Curr. Org. Chem. 16 (6), 692–714. 10.2174/138527212799957995 [DOI] [Google Scholar]
  32. Davies S. S., Guo L. (2014). Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified Phospholipids. Chem. Phys. Lipids 181, 1–33. 10.1016/j.chemphyslip.2014.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Deepika A., Minu S., Surinder S. (2013). The role og natural antioxidants as potential therapeutic agent in nephrolithiasis. Asian J. Pharm. Clin. Res. 6 (3), 48–53. [Google Scholar]
  34. Del Rio D., Rodriguez-Mateos A., Spencer J. P. E., Tognolini M., Borges G., Crozier A. (2013). Dietary (Poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal 18 (14), 1818–1892. 10.1089/ars.2012.4581 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dela cruz C. S., Tanoue L. T., Matthay R. A. (2011). Lung cancer: Epidemiology, etiology, and prevention. Clin. Chest Med. 32 (4), 605–644. 10.1016/j.ccm.2011.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Duni A., Liakpoulos B., Roumeliotis S., Peschos D., Dounousi E. (2019). Oxidative stress in the pathogenesis and evolution of chronic kidney disease: Untangling ariadne’s thread. Int. J. Mol. Sci. 20 (15), 3711. 10.3390/ijms20153711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Einbond L. S., Wu H., Kashiwazaki R., He K., Roller M., Su T., et al. (2012). Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 83 (7), 1160–1168. 10.1016/j.fitote.2012.07.006 [DOI] [PubMed] [Google Scholar]
  38. Elseweidy M. M. (2011). Role of natural antioxidants in gastritis. Gastritis and gastric cancer-new insights in gastro protection, diagnosis and treatments. InTech. 10.5772/24336 [DOI] [Google Scholar]
  39. Elshamy A. I., Abd-ElGawad A. M., El Gendy A. E. N. G., Assaeed A. M. (2019). Chemical characterization of Euphorbia heterophylla L. essential oils and their antioxidant activity and allelopathic potential on Cenchrus echinatus L. Chem. Biodivers. 16 (5), e1900051. 10.1002/cbdv.201900051 [DOI] [PubMed] [Google Scholar]
  40. Engwa G. A. (2018). “Free radicals and the role of plant phytochemicals as antioxidants against oxidative stress-related diseases,” in Phytochemicals-source of antioxidants and role in disease prevention (InTech; ). 10.5772/intechopen.76719 [DOI] [Google Scholar]
  41. Fadel O., El Kirat K., Morandat S. (2011). The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ . Biochim. Biophys. Acta-Biomembr. 1808 (12), 2973–2980. 10.1016/j.bbamem.2011.08.011 [DOI] [PubMed] [Google Scholar]
  42. Fidyt K., Fiedorowicz A., Strzadala L., Szummy A. (2016). Β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. Cancer Med. 5 (10), 3007–3017. 10.1002/cam4.816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Fiedor J., Burda K. (2014). Potential role of carotenoids as antioxidants in human health and disease. Nutrients 6 (2), 466–488. 10.3390/nu6020466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Flieger J., Flieger W., Baj J., Maciejewski R. (2021). Antioxidants: Classification, natural sources, activity/capacity measurements, and usefulness for the synthesis of nanoparticles. Mater. (Basel) 14 (15), 4135. 10.3390/ma14154135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Flora S. J. S. (2009). Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid. Med. Cell. Longev. 2 (4), 191–206. 10.4161/oxim.2.4.9112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. George B. P., Chandran R., Abrahamse H. (2021). Role of phytochemicals in cancer chemoprevention: Insights. Antioxidants 10 (9), 1455. 10.3390/antiox10091455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Gómez-Zorita S., González-Arceo M., Fernández-Auintela A., Eseberri I., Trepiana J., Portillo M. P. (2020). Scientific evidence supporting the beneficial effects of isoflavones on human health. Nutrients 12 (12), 3853. 10.3390/nu12123853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Grune T., Lietz G., Palou A., Ross A. C., Stahl W., Tang G., et al. (2010). β-carotene is an important vitamin A source for humans. J. Nutr. 140 (12), 2268S–2285S. 10.3945/jn.109.119024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Gülçin I., Elias R., Gepdiremen A., Chea A., Topal F. (2010). Antioxidant activity of bisbenzylisoquinoline alkaloids from Stephania rotunda: Cepharanthine and fangchinoline. J. Enzyme Inhib. Med. Chem. 25 (1), 44–53. 10.3109/14756360902932792 [DOI] [PubMed] [Google Scholar]
  50. Hacioglu G., Senturk A., Ince I., Alver A. (2016). Assessment of oxidative stress parameters of brain-derived neurotrophic factor heterozygous mice in acute stress model. Iran. J. Basic Med. Sci. 19 (4), 388–393. PMID: 27279982. PMCID: PMC4887711. [PMC free article] [PubMed] [Google Scholar]
  51. Hacişevki A., Baba B. (2018). An overview of melatonin as an antioxidant molecule: A biochemical approach. IntechOpen. 10.5772/intechopen.79421 [DOI] [Google Scholar]
  52. Ho E., Clarke J. D., Dashwood R. H. (2009). Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J. Nutr. 139 (12), 2393–2396. 10.3945/jn.109.113332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Hodges R. E., Minich D. M. (2015). Modulation of metabolic detoxification pathways using foods and food-derived components: A scientific review with clinical application. J. Nutr. Metab. 2015, 1–23. 10.1155/2015/760689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Hritcu L., Ionita R., Postu P. A., Gupta G. K., Turkez H., Lima T. C., et al. (2017). Antidepressant flavonoids and their relationship with oxidative stress. Oxid. Med. Cell. Longev. 2017, 1–18. 10.1155/2017/5762172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Iannone A., Rota C., Bergamini S., Tomasi A., Canfield L. M. (1998). Antioxidant activity of carotenoids: An electron-spin resonance study on β-carotene and lutein interaction with free radicals generated in a chemical system. J. Biochem. Mol. Toxicol. 12 (5), 299–304. [DOI] [PubMed] [Google Scholar]
  56. Iqbal J., Abbasi B. A., Ahmad R., Mahmood T., Kanwal S., Ali B., et al. (2018). Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications. Biomed. Pharmacother. 108, 752–756. 10.1016/j.biopha.2018.09.096 [DOI] [PubMed] [Google Scholar]
  57. Ivanov V., Carr A. C., Frei B. (2001). Red wine antioxidants bind to human lipoproteins and protect them from metal ion-dependent and -independent oxidation. J. Agric. Food Chem. 49 (9), 4442–4449. 10.1021/jf010117m [DOI] [PubMed] [Google Scholar]
  58. Jain D., Chaudhary P., Kotnala A., Hossain R., Bisht K., Hossain M. N. (2020). Hepatoprotective activity of medicinal plants: A mini review. J. Med. Plants Stud. 8 (5), 183–188. 10.22271/plants.2020.v8.i5c.1212 [DOI] [Google Scholar]
  59. Jamshidi S., Beigrezaei S., Faraji H. (2018). A review of probale effects of antioxidants on DNA damage. Int. J. Pharm. Phytopharm. Res. 8 (5), 72–79. [Google Scholar]
  60. Jančová P., Šiller M. (2012). “Phase II drug metabolism,” in Topics on drug metabolism (InTech; ). 10.5772/29996 [DOI] [Google Scholar]
  61. Jezierska-Drutel A., Rosenzweig S. A., Neumann C. A. (2013). Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv. Cancer Res. 119, 107–125. 10.1016/B978-0-12-407190-2.00003-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Jomova K., Valko M. (2013). Health protective effects of carotenoids and their interactions with other biological antioxidants. Eur. J. Med. Chem. 70C (9), 102–110. 10.1016/j.ejmech.2013.09.054 [DOI] [PubMed] [Google Scholar]
  63. Kahkeshani N., Farzaei F., Fotouhi M., Alavi S. S., Bahramsoltani R., Naseri R., et al. (2019). Pharmacological effects of gallic acid in health and diseases: A mechanistic review. Iran. J. Basic Med. Sci. 22 (3), 225–237. 10.22038/ijbms.2019.32806.7897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Kamat P. K., Kalani A., Rai S., Swarnkar S., Tota S., Nath C., et al. (2016). Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer’s disease: Understanding the therapeutics strategies. Mol. Neurobiol. 53 (1), 648–661. 10.1007/s12035-014-9053-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Kasala E. R., Bodduluru L. N., Barua C. C., Madhana R. M., Dahiya V., Budhani M. K., et al. (2016). Chemopreventive effect of chrysin, a dietary flavone against benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pharmacolo Rep. 68 (2), 310–318. 10.1016/j.pharep.2015.08.014 [DOI] [PubMed] [Google Scholar]
  66. Kashyap D., Tuli H. S., Sak K., Garg V. K., Goel N., Punia S., et al. (2019). Role of reactive oxygen species in cancer progression. Curr. Pharmacol. Rep. 5 (1), 79–86. 10.1007/s40495-019-00171-y [DOI] [Google Scholar]
  67. Kaur J., Kukreja S., Kaur A., Malhotra N., Kaur R. (2012). The oxidative stress in cataract patients. J. Clin. Diagn Res. 6 (10), 1629–1632. 10.7860/JCDR/2012/4856.2626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kaur P., Purewal S. S., Sandhu K. S., Kaur M. (2019). DNA damage protection: An excellent application of bioactive compounds. Bioresour. Bioprocess. 6, 2. 10.1186/s40643-019-0237-9 [DOI] [Google Scholar]
  69. Kaurinovic B., Vastag D. (2019). “Flavononoids and phenolic acids as potential natural antioxidants,” in Antioxidants (IntechOpen; ). 10.5772/intechopen.88731 [DOI] [Google Scholar]
  70. Kelm M. A., Nair M. G., Strasburd G. M., DeWitt D. L. (2000). Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7 (1), 7–13. 10.1016/S0944-7113(00)80015-X [DOI] [PubMed] [Google Scholar]
  71. Khan N., Adhami V. M., Mikhtar H. (2010). Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr. Relat. Cancer 17 (1), R39–R52. 10.1677/ERC-09-0262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Khanna S., Jaiswal K. S., Gupta B. (2017). Managing rheumatoid arthritis with dietary interventions. Front. Nutr. 4, 52. 10.3389/fnut.2017.00052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Kiliç I., Yeşiloğlu Y. (2013). Spectroscopic studies on the antioxidant activity of p-coumaric acid. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 115, 719–724. 10.1016/j.saa.2013.06.110 [DOI] [PubMed] [Google Scholar]
  74. Kim S. J., Cheresh P., Janlonski R. P., Williams D. B., Kamp D. W. (2015). The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis. Int. J. Mol. Sci. 16 (9), 21486–21519. 10.3390/ijms160921486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Kiokias S., Proestos C., Orepoulou V. (2020). Phenolic acids of plant origin-a review on their antioxidant activity in vitro (O/W emulsion systems) along with their in vivo health biochemical properties. Foods 9 (4), 534. 10.3390/foods9040534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Klaunig J. E., Kamendulis L. M. (2004). The role of oxidative stress in carcinogenesis. Annu. Rev. Phamacol. Toxicol. 44, 239–267. 10.1146/annurev.pharmtox.44.101802.121851 [DOI] [PubMed] [Google Scholar]
  77. Klimaczewski C. V., Saraiva R. D. A., Roos D. H., Boligon A., Athayde M. L., Kamdem J. P., et al. (2014). Antioxidant activity of Peumus boldus extract and alkaloid boldine against damage induced by Fe(II)-citrate in rat liver mitochondria in vitro . Ind. Crop Prod. 54, 240–247. 10.1016/j.indcrop.2013.11.051 [DOI] [Google Scholar]
  78. Kowald A., Lehrach H., Klipp E. (2006). Alternative pathways as mechanism for the negative effects associated with overexpression of superoxide dismutase. J. Theor. Bio. 238 (4), 828–840. 10.1016/j.jtbi.2005.06.034 [DOI] [PubMed] [Google Scholar]
  79. Kumar S., Agnihotri N. (2021). Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer. Mol. Cell. Biochem. 476 (4), 1765–1781. 10.1007/s11010-020-04044-7 [DOI] [PubMed] [Google Scholar]
  80. Kumar N., Goel N. (2019). Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol. Rep. 24, e00370. 10.1016/j.btre.2019.e00370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Kurutas E. B. (2016). The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: Current state. Nutr. J. 15, 71. 10.1186/s12937-016-0186-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Landis-Piwowar K. R., Iyer N. R. (2014). Cancer chemoprevention: Current state of the art. Cancer Growth Metastasis 10 (7), CGM.S11288–25. 10.4137/cgm.s11288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Li S., Tan H. Y., Wang N., Zhang Z. J., Lao L., Wong C. W., et al. (2015). The role of oxidative stress and antioxidants in liver diseases. Int. J. Mol. Sci. 16 (11), 26087–26124. 10.3390/ijms161125942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Liakopoulos B., Roumeliotis S., Gorny X., Dounousi E., Mertens P. R. (2017). Oxidative stress in hemodialysis patients: A review of the literature. Oxid. Med. Cell. Longev. 2017, 1–22. 10.1155/2017/3081856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Limmongkon A., Pankam J., Somboon T., Wongshaya P., Nopprang P. (2019). Evaluation of the DNA damage protective activity of the germinated peanut (Arachis hypogaea) in relation to antioxidant and anti-inflammatory activity. LWT 101 (18), 259–268. 10.1016/j.lwt.2018.11.009 [DOI] [Google Scholar]
  86. Lipinski B. (2011). Hydroxyl radical and its scavengers in health and disease. Oxid. Med. Cell. Longev. 2011, 1–9. 10.1155/2011/809696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Liu X., Chen Z. (2017). The pathophysiological role of mitochondrial oxidative stress in lung diseases. J. Transl. Med. 15, 207. 10.1186/s12967-017-1306-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Lobo B., Patil A., Phatak A., Chandra N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Phacog Rev. 4 (8), 118–126. 10.4103/0973-7847.70902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Lubos E., Loscalzo J., Handy D. E. (2011). Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal 15 (7), 1957–1997. 10.1089/ars.2010.3586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Lv L., Zhang W., Li T., Jiang L., Lu X., Lin J. (2020). Hispidulin exhibits potent anticancer activity in vitro and in vivo through activating ER stress in non-small cell lung cancer cells. Oncol. Rep. 43 (6), 1995–2003. 10.3892/or.2020.7568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Mancuso C., Barone E., Guido P., Miceli F., Di Domenico F., Perluigi M., et al. (2012). Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro . Neurosci. Lett. 518 (2), 101–105. 10.1016/j.neulet.2012.04.062 [DOI] [PubMed] [Google Scholar]
  92. Maraldi T. (2013). Natural compounds as modulators of NADPH oxidases. Oxid. Med. Cell. Longev. 2013, 1–10. 10.1155/2013/271602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Marnett L. J. (2000). Oxyradicals and DNA damage. Carcinogenesis 21 (3), 361–370. 10.1093/carcin/21.3.361 [DOI] [PubMed] [Google Scholar]
  94. Maynard R. L. (2015). The effects on health of ambient particles: Time for an agonizing reappraisal? Cell. Biol. Toxicol. 31 (3), 131–147. 10.1007/s10565-015-9296-7 [DOI] [PubMed] [Google Scholar]
  95. Mehmood T., Maryam A., Ghramh H. A., Khan M., Ma T. (2017). Deoxyelephantopin and isodeoxyelephantopin as potential anticancer agents with effects on multiple signaling pathways. Molecules 22 (6), 1013. 10.3390/molecules22061013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Mehta R. G., Murillo G., Naithani R., Peng X. (2010). Cancer chemoprevention by natural products: How far have we come? Pharm. Res. 27 (6), 950–961. 10.1007/s11095-010-0085-y [DOI] [PubMed] [Google Scholar]
  97. Milder I. E. J., Feskens E. J. M., Arts I. C. W., Bas Bueno De Mesquita H., Hollman P. C. H., Kromhout D. (2005). Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J. Nutr. 135 (5), 1202–1207. 10.1093/jn/135.5.1202 [DOI] [PubMed] [Google Scholar]
  98. Mizanur Rahaman Md., Hossain R., Herrera-Bravo J., Torequl Islam M., Atolani O., Stephen Adeyemi O., et al. (2023). Natural antioxidants from some fruits, seeds, foods, natural products, and associated health benefits: An update. Food Science & Nutrition 11 (4), 1657–1670. 10.1002/fsn3.3217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Monteiro Espíndola K. M., Ferreira R. G., Mosquera Narvaez L. E., Rocha Silva Rosario A. C., Machado Da Silva A. H., Bispo Silva A. G., et al. (2019). Chemical and pharmacological aspects of caffeic acid and its activity in hepatocarcinoma. Front. Oncol. 9, 541. 10.3389/fonc.2019.00541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Morais M. C. C., Luqman S., Kondratyuk T. O., Petronio M. S., Regasini L. O., Silva D. H. S., et al. (2010). Suppression of TNF-α induced NFκB activity by gallic acid and its semi-synthetic esters: Possible role in cancer chemoprevention. Nat. Prod. Res. 24 (18), 1758–1765. 10.1080/14786410903335232 [DOI] [PubMed] [Google Scholar]
  101. Mostafa Abd El-Aal H. A. H. (2012). “Lipid peroxidation end-products as a key od oxidative stress: Effect of antioxidant on their production and transfer of free radicals,” in Lipid peroxidation (InTech; ). 10.5772/45944 [DOI] [Google Scholar]
  102. Mourente G., Bell J. G., Tocher D. R. (2007). Does dietary tocopherol level affect fatty acid metabolism in fish? Fish. Physiol. Biochem. 33 (3), 269–280. 10.1007/s10695-007-9139-4 [DOI] [Google Scholar]
  103. Nandi A., Yan L. J., Jana C. K., Das N. (2019). Role of catalase in oxidative stress- and age-associated degenerative diseases. Oxid. Med. Cell. Longev. 2019, 1–19. 10.1155/2019/9613090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Nita M., Grzybowski A. (2016). The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid. Med. Cell. Longev. 2016, 1–23. 10.1155/2016/3164734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Nóbrega-Pereira S., Fernandez-Marcos P. J., Brioche T., Gomez-Cabrera M. C., Salvodar-Pascual A., Flores J. M., et al. (2016). G6PD protects from oxidative damage and improves healthspan in mice. Nat. Commun. 7, 10894. 10.1038/ncomms10894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Noctor G., Queval G., Mhamdi A., Chaouch S., Foyer C. H. (2011). Glutathione. Arabidopsis Book 9, 1–32. 10.1199/tab.0142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Noh S., Go A., Kim D. B., Park M., Jeon H. W., Kim B. (2020). Role of antioxidant natural products in management of infertility: A review of their medicinal potential. Antioxidants 9 (10), 957. 10.3390/antiox9100957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Obaid Aldulaimi A. K., Abdul Azziz S. S. S., Bakri Y. M., Nafiah M. A., Aowda S. A., Awang K., et al. (2019). Two New isoquinoline alkaloids from the bark of Alphonsea cylindrica King and their antioxidant activity. Phytochem. Lett. 29, 110–114. 10.1016/j.phytol.2018.11.022 [DOI] [Google Scholar]
  109. Oberreuther-Moschner D. L., Rechkemmer G., Pool-Zobel B. L. (2005). Basal colon crypt cells are more sensitive than surface cells toward hydrogen peroxide, a factor of oxidative stress. Toxicol. Lett. 159 (3), 212–218. 10.1016/j.toxlet.2005.05.008 [DOI] [PubMed] [Google Scholar]
  110. Pacher P., Beckman J. S., Liaudet L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (1), 315–424. 10.1152/physrev.00029.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Padayatty S. J., Levine M. (2016). Vitamin C: The known and the unknown and goldilocks. Oral Dis. 22 (6), 463–493. 10.1111/odi.12446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Panahi Y., Fazlolahzadeh O., Atkin S. L., Majeed M., Butler A. E., Johnston T. P., et al. (2019). Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. J. Cell. Physiol. 234 (2), 1165–1178. 10.1002/jcp.27096 [DOI] [PubMed] [Google Scholar]
  113. Panche A. N., Diwan A. D., Chandra S. R. (2016). Flavonoids: An overview. J. Nutr. Sci. 5, e47. 10.1017/jns.2016.41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Park H. S., Kim S. R., Lee Y. C. (2009). Impact of oxidative stress on lung diseases. Respirology 14 (1), 27–38. 10.1111/j.1440-1843.2008.01447.x [DOI] [PubMed] [Google Scholar]
  115. Patel H. S., Kim S. R., Lee Y. C., Sutariya V. (2018). Role of nutritional factors in pathogenesis of cancer. Food Qual. Saf. 2 (1), 27–36. 10.1093/fqsafe/fyx033 [DOI] [Google Scholar]
  116. Pehlivan F. E. (2017). Vitamin C: An antioxidant agent. Vitamin C. InTech. 10.5772/intechopen.69660 [DOI] [Google Scholar]
  117. Pereira A. C., Martel F. (2014). Oxidative stress in pregnancy and fertility pathologies. Cell. Biol. Toxicol. 30 (5), 301–312. 10.1007/s10565-014-9285-2 [DOI] [PubMed] [Google Scholar]
  118. Perše M. (2013). Oxidative stress in the pathologies of colorectal cancer: Cause or consequence. Biomed. Res. Int. 2013, 1–9. 10.1155/2013/725710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Peters A. L., Van Noorden C. J. F. (2009). Glucose-6-phosphate dehydrogenase deficiency and malaria: Cytochemical detection of heterozygous G6PD deficiency in women. J. Histochem. Cytochem. 57 (11), 1003–1011. 10.1369/jhc.2009.953828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Phaniendra A., Jestadi D. B., Periyasamy L. (2015). Free radicals: Properties, sources, targets, and their implication in various diseases. Indian J. Clin. biochem. 30 (1), 11–26. 10.1007/s12291-014-0446-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Ponist S., Zloh M., Bauerova K. (2019). “Impact of oxidative stress on inflammation in rheumatoid and adjuvant arthritis: Damage to lipids, proteins, and enzymatic antioxidant defense in plasma and different tissues,” in Animal models in medicine and biology (IntechOpen.). 10.5772/intechopen.89480 [DOI] [Google Scholar]
  122. Porter T. D. (2002). The roles of cytochromeb5 in cytochrome P450 reactions. J. Biochem. Mol. Toxicol. 16 (6), 311–316. 10.1002/jbt.10052 [DOI] [PubMed] [Google Scholar]
  123. Radhakrishnan E. K., Bava S. V., Narayanan S. S., Nath L. R., Thulasidasan A. K. T., Soniya E. V., et al. (2014). [6]-gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signaling. PLoS One 9 (8), e104401. 10.1371/journal.pone.0104401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Rajendran P., Rengarajan T., Nandakumar N., Divya H., Nishigaki I. (2015). Mangiferin in cancer chemoprevention and treatment: Pharmacokinetics and molecular targets. J. Recept. Signal Transduct. Res. 35 (1), 76–84. 10.3109/10799893.2014.931431 [DOI] [PubMed] [Google Scholar]
  125. Ratliff B. B., Abdulmahdi W., Pawar R., Wolin M. S. (2016). Oxidant mechanisms in renal injury and disease. Antioxid. Redox Signal 25 (3), 119–146. 10.1089/ars.2016.6665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Reddy A. C., Lokesh B. R. (1992). Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol. Cell. Biochem. 111 (1-2), 117–124. 10.1007/BF00229582 [DOI] [PubMed] [Google Scholar]
  127. Rendic S., Guengerich F. P. (2012). Contributions of human enzymes in carcinogen metabolism. Chem. Res. Toxicol. 25 (7), 1316–1383. 10.1021/tx300132k [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Reuter S., Gupta S. C., Chaturvedi M. M., Aggarwal B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 49 (11), 1603–1616. 10.1016/j.freeradbiomed.2010.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Riddick D. S., Ding X., Wolf C. R., Porter T. D., Pandey A. V., Zhang Q. Y., et al. (2013). NADPH-Cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology. Drug Metab. Dispos. 41 (1), 12–23. 10.1124/dmd.112.048991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Rocha-González H. I., Ambriz-Tututi M., Granados-Soto V. (2008). Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci. Ther. 14 (3), 234–247. 10.1111/j.1755-5949.2008.00045.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Roumeguére T., Sfeir J., El Rassy E., Albisinni S., Van Antwerpen P., Boudjeltia K. Z., et al. (2017). Oxidative stress and prostatic diseases. Mol. Clin. Oncol. 7 (5), 723–728. 10.3892/mco.2017.1413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Saleh S. R., Attia R., Ghareeb D. A. (2018). The ameliorating effect of berberine-rich fraction against gossypol-induced testicular inflammation and oxidative stress. Oxid. Med. Cell. Longev. 2018, 1–13. 10.1155/2018/1056173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Schumacker P. T., Gillespie M. N., Nakahira K., Choi A. M. K., Crouser E. D., Piantadosi C. A., et al. (2014). Mitochondria in lung biology and pathology: More than just a powerhouse. Am. J. Physiol. Lung Cell. Mol. Physiol. 306 (11), L962–L974. 10.1152/ajplung.00073.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Shahidi F., Zhong Y. (2015). Measurement of antioxidant activity. J. Funct. Foods 18 (B), 757–781. 10.1016/j.jff.2015.01.047 [DOI] [Google Scholar]
  135. Sharifi-Rad J., Rapposell S., Sestito S., Herrera-Bravo J., Arancibia-Diaz A., Salaza L. A., et al. (2022). Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation. J. Pers. Med. 12 (9), 1515. 10.3390/jpm12091515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Shen T. S., Hsu Y. K., Huang Y. F., Chen H. Y., Hsieh C. P., Chen C. L. (2019). Licochalcone a suppresses the proliferation of osteosarcoma cells through autophagy and ATM-Chk2 activation. Molecules 24 (13), 2435. 10.3390/molecules24132435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Sindhi V., Gupta V., Sharma K., Bhatnagar S., Kumari R., Dhaka N. (2013). Potential applications of antioxidants – a review. J. Pharm. Res. 7 (9), 828–835. 10.1016/j.jopr.2013.10.001 [DOI] [Google Scholar]
  138. Singh S., Nagalakshmi D., Sharma K. K., Ravichandiran V. (2021). Natural antioxidants for neuroinflammatory disorders and possible involvement of Nrf2 pathway: A review. Heliyon 7 (2), e06216. 10.1016/j.heliyon.2021.e06216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Skala E., Sitarek P., Rózalski M., Krajewska U., Szemraj J., Wysokińska H., et al. (2016). Antioxidant and DNA repair stimulating effect of extracts from transformed and normal roots of Rhaponticum carthamoides against oxidative stress and DNA damage in CHO cells. Oxid. Med. Cell. Longev. 2016, 1–11. 10.1155/2016/5753139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Snezhkina A. V., Kudryavtseva A. V., Kardymon O. L., Savvateeva M. V., Melnikova N. V., Krasnov G. S., et al. (2020). ROS generation and antioxidant defense systems in normal and malignant cells. Oxid. Med. Cell. Longev. 2019, 1–17. 10.1155/2019/6175804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Stanton R. C. (2012). Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64 (5), 362–369. 10.1002/iub.1017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Stephenson E., Nathoo N., Mahjoub Y., Dunn J. F., Yong V. W. (2014). Iron in multiple sclerosis: Roles in neurodegeneration and repair. Nat. Rev. Neurol. 10 (8), 459–468. 10.1038/nrneurol.2014.118 [DOI] [PubMed] [Google Scholar]
  143. Steward W. P., Brown K. (2013). Cancer chemoprevention: A rapidly evolving field. Br. J. Cancer 109 (1), 1–7. 10.1038/bjc.2013.280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Story E. N., Kopec R. E., Schwartz S. J., Harris G. K. (2010). An update on the health effects of tomato lycopene. Annu. Rev. Food Sci. Technol. 1, 189–210. 10.1146/annurev.food.102308.124120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Strzelak A., Ratajczak A., Adamiec A., Feleszko W. (2018). Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma, and other lung diseases: A mechanistic review. Int. J. Environ. Res. Public Health. 15 (5), 1033. 10.3390/ijerph15051033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Su L.-J., Zhang J.-H., Gomez H., Murugan R., Hong X., Xu D., et al. (2019). Reactive oxygen species induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid. Med. Cell. Longev. 2019, 1–13. 10.1155/2019/5080843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Suzuki Y., Ishihara M., Segami T., Ito M. (1998). Anti-ulcer effects of antioxidants, quercetin, α-tocopherol, nifedipine and tetracycline in rats. Jpn. J. Pharmacol. 78 (4), 435–441. 10.1254/jjp.78.435 [DOI] [PubMed] [Google Scholar]
  148. Talirevic E., Sehovic J. (2012). Quercetin in the treatment of dyslipidemia. Med. Arh. 66 (2), 87–88. 10.5455/medarh.2012.66.87-88 [DOI] [PubMed] [Google Scholar]
  149. Tan B. L., Norhaizan M. E., Liew W.-P.-P., Rahman H. S. (2018). Antioxidant and oxidative stress: A mutual interplay in age-related diseases. Front. Pharmacol. 9, 1162. 10.3389/fphar.2018.01162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Tan H. K., Yates E., Lilly K., Dhanda A. D. (2020). Oxidative stress in alcohol-related liver disease. World J. Hepatol. 12 (7), 332–349. 10.4254/wjh.v12.i7.332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Tapiero H., Townsend D. M., Tew K. D. (2004). The role of carotenoids in the prevention of human pathologies. Biomed. Pharmacother. 58 (2), 100–110. 10.1016/j.biopha.2003.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Tewari D., Samoila O., Gocan D., Mocan A., Moldovan C., Devkota H. P., et al. (2019). Medicinal plants and natural products used in cataract management. Front. Pharmacol. 10, 466. 10.3389/fphar.2019.00466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Thielecke F., Rahn G., Bohnke J., Adams F., Birken feld A. L., Jordan J., et al. (2010). Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: A pilot study. Eur. J. Clin. Nutr. 64 (7), 704–713. 10.1038/ejcn.2010.47 [DOI] [PubMed] [Google Scholar]
  154. Traber M. G., Atkinson J. (2007). Vitamin E. Antioxidant and nothing more. Free Radic. Biol. Med. 43 (1), 4–15. 10.1016/j.freeradbiomed.2007.03.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Traber M. G., Stevens J. F. (2011). Vitamins C and E: Beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 51 (5), 1000–1013. 10.1016/j.freeradbiomed.2011.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Ushio-Fukai M., Nakamura Y. (2008). Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266 (1), 37–52. 10.1016/j.canlet.2008.02.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Usman M., Khan W. R., Yousaf N., Akram S., Murtaza G., Kudus K. A., et al. (2022). Exploring the phytochemicals and anti-cancer potential of the members of fabaceae family: A comprehensive review. Molecules 27 (12), 3863. 10.3390/molecules27123863 [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Valavanidis A., Vlachogianni T., Fiotakis K., Loridas S. (2013). Pulmonary oxidative stress, inflammation and cancer. Respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int. J. Environ. Res. Public Health 10 (9), 3886–3907. 10.3390/ijerph10093886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telsar J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 39 (1), 44–84. 10.1016/j.biocel.2006.07.001 [DOI] [PubMed] [Google Scholar]
  160. Velayutham P., Babu A., Liu D. (2008). Green tea catechins and cardiovascular health: An update. Curr. Med. Chem. 15 (18), 1840–1850. 10.2174/092986708785132979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Verma D., Mudgal B., Chaudhary P., Mahakur B., Mitra D., Pant K., et al. (2020). Medicinal plants of uttarkahand (India) and their benefits in the treatment of tuberculosis: Current perspectives. GJBB 9 (3), 75–78. 10.1080/19338244.2019.1574703 [DOI] [Google Scholar]
  162. Wang Z., Wang N., Han S., Wang D., Mo S., Yu L., et al. (2013). Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One 8 (7), e68566. 10.1371/journal.pone.0068566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Wang Z., Li Z., Ye Y., Xie L., Li W. (2016). Oxidative stress and liver cancer. Etiology and therapeutic targets. Oxid. Med. Cell. Longev. 2016, 1–10. 10.1155/2016/7891574 [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Wang H H., Ge X., Qu H., Wang N., Zhou J., Xu W., et al. (2020). <p&gt;Glycyrrhizic acid inhibits proliferation of gastric cancer cells by inducing cell cycle arrest and apoptosis</p&gt;. Cancer Manag. Res. 12, 2853–2861. 10.2147/CMAR.S244481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Wang R R., Zhou J., Shi G., Liu Y., Yu D. (2020). Aporphine and phenanthrene alkaloids with antioxidant activity from the roots of Stephania tetrandra. Fitoterapia 143, 104551. 10.1016/j.fitote.2020.104551 [DOI] [PubMed] [Google Scholar]
  166. Wilkinson I. V., Clapper M. L. (1997). Detoxication enzymes and chemoprevention. Proc. Soc. Exp. Biol. Med. 216 (2), 192–200. 10.3181/00379727-216-44169 [DOI] [PubMed] [Google Scholar]
  167. Woźniak M., Makuch S., Winograd K., Wiśniewski J., Ziólkowski P., Agrawal S. (2020). 6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions. BMC Complement. Med. Ther. 20, 141. 10.1186/s12906-020-02913-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Wu J., Jin Y., Zhang M. (2021). Evaluation on the physicochemical and digestive properties of melanoidin from black garlic and their antioxidant activities in vitro . Food Chem. 340, 127934. 10.1016/j.foodchem.2020.127934 [DOI] [PubMed] [Google Scholar]
  169. Yadav P., Chaudhary P., Singh D., Chaudhary S., Prakash A., Janmeda P. (2023). Pharmacognostic, antimicrobial and antiarthritic properties of Heteropogon contortus (L). Biochem. Cell. Arch. 23 (1), 651–661. 10.51470/bca.2023.23.1.651 [DOI] [Google Scholar]
  170. Yang W., Chen X., Li Y., Guo S., Wang Z., Yu X. (2020). Advances in pharmacological activities of terpenoids. Nat. Prod. Commun. 15 (3), 1934578X2090355. 10.1177/1934578X20903555 [DOI] [Google Scholar]
  171. Yi H., Peng H., Wu X., Kuang T., Zhang J., Du L., et al. (2021). The therapeutic effects and mechanisms of quercetin on metabolic diseases: Pharmacological data and clinical evidence. Oxid. Med. Cell. Longev. 2021, 1–16. 10.1155/2021/6678662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Yuan X., Xu C., Pan Z., Keum Y. S., Kim J. H., Shen G., et al. (2006). Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and jnk signaling pathway in HepG2 cells: Activation of nrf2-ARE signaling by BHA and MAPK. Mol. Carcinog. 45 (11), 841–850. 10.1002/mc.20234 [DOI] [PubMed] [Google Scholar]
  173. Zduńska K., Dana A., Kolodziejczak A., Rotsztejn H. (2018). Antioxidant properties of ferulic acid and its possible application. Skin. Pharmacol. Physiol. 31 (6), 332–336. 10.1159/000491755 [DOI] [PubMed] [Google Scholar]
  174. Zeng Q., Zhang Y., Zhang W., Guo Q. (2020). Baicalein suppresses the proliferation and invasiveness of colorectal cancer cells by inhibiting snail-induced epithelial-mesenchymal transition. Mol. Med. Rep. 21 (6), 2544–2552. 10.3892/mmr.2020.11051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Zhang W., Wang M., Xie H. Y., Zhou L., Meng X. Q., Shi J., et al. (2007). Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transpl. Proc. 39 (5), 1332–1337. 10.1016/j.transproceed.2006.11.021 [DOI] [PubMed] [Google Scholar]
  176. Zhang J. J., Wei Y., Fang Z. (2019). Ozone pollution: A major health hazard worldwide. Front. Immunol. 10, 2518. 10.3389/fimmu.2019.02518 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Chemistry are provided here courtesy of Frontiers Media SA

RESOURCES